REVIEW article

Front. Cell Dev. Biol., 02 March 2022

Sec. Molecular and Cellular Oncology

Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.752818

Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis

  • 1. Longgang District People´s Hospital of Shenzhen, The Second Affiliated Hospital of The Chinese University of Hong Kong, Shenzhen, China

  • 2. School of Basic Medical Sciences, Anhui Medical University, Hefei, China

Article metrics

View details

40

Citations

7k

Views

3,1k

Downloads

Abstract

Tumor-derived exosomes (TDEs) are actively produced and released by tumor cells and carry messages from tumor cells to healthy cells or abnormal cells, and they participate in tumor metastasis. In this review, we explore the underlying mechanism of action of TDEs in tumor metastasis. TDEs transport tumor-derived proteins and non-coding RNA to tumor cells and promote migration. Transport to normal cells, such as vascular endothelial cells and immune cells, promotes angiogenesis, inhibits immune cell activation, and improves chances of tumor implantation. Thus, TDEs contribute to tumor metastasis. We summarize the function of TDEs and their components in tumor metastasis and illuminate shortcomings for advancing research on TDEs in tumor metastasis.

Background

Exosomes are extracellular vesicles, approximately 30–150 nm in diameter, that contain functional biomolecules, such as proteins, RNA, DNA, and lipids, and can interact with recipient cells (Balaj et al., 2011; Choi et al., 2013; Peinado et al., 2011; Raposo and Stoorvogel, 2013; Skog et al., 2008; Thakur et al., 2014; Thery et al., 2009; Valadi et al., 2007). Exosomes are present in various body fluids and are regarded as a key component of intercellular communication. Tumor cell-, stromal cell-, or even normal cell–derived exosomes play an important role in tumor progression and can induce angiogenesis and accelerate metastasis (Hood et al., 2011; Luga et al., 2012; Peinado et al., 2012). The components and functions of the exosomes depend on the cell types; some studies have shown many differences in the contents and release rate in different types of cells. But, the complete mechanism and process have not yet been elucidated and need to be further explored. Metastasis is the leading cause of tumor-induced death and is a complex process involving local invasion, survival, and evasion from immunosurveillance, invasion into circulation, and extravasation at secondary organs (Fidler and Kripke, 2015; Wan et al., 2013). Tumor-derived exosomes (TDEs) are a significant component of the tumor microenvironment and are involved in promoting tumor metastasis through several mechanisms, including acquiring primary tumor migration capacity, tumor angiogenesis, escaping immune system organotropic metastasis, forming the pre-metastatic niche, and metastatic tumor growth in the secondary site.

In this review, we summarize the function of exosomes in every aspect of cancer metastasis (Figure 1) to provide a better systematic comprehension of the role of exosomes in tumor metastasis and propose practical implications of early diagnosis, treatment, and prognostic methods for cancer.

FIGURE 1

FIGURE 1

Function of TDEs in tumor metastasis. TDEs are mainly involved in tumor metastasis through five aspects. Step 1: acquisition of tumor migration ability; Step 2: angiogenesis; Step 3: immunosuppression; Step 4: localization of metastatic sites; and Step 5: enhancement of proliferation ability of tumor cells after migration.

Tumor-Derived Exosomes Enhance the Migration Ability of Tumor Cells

Tumor-Derived Exosomes Promote Epithelial–Mesenchymal Transition to Initiate Metastasis

Epithelial–mesenchymal transition (EMT) frequently initiates the metastatic process (Li et al., 2021). Epithelial tumor cells acquire mesenchymal characteristics under the influence of cancer-associated fibroblasts (CAFs) in the tumor stroma (Diepenbruck and Christofori, 2016). Epithelial markers, including E-cadherin, zona occludens 1 (ZO-1), cytokeratins, desmoplakin, and laminin, are downregulated, and mesenchymal markers, including N-cadherin, β-catenin, and vimentin, are upregulated (Sommers et al., 1994; Li Y. et al., 2019). During EMT, tumor cells lose their apical–basal polarity, basement anchoring, and cell–cell junctions and switch to a low proliferation state with enhanced migratory and invasion capabilities (Basil et al., 2020). Once the tumor cells reach a distant pre-metastatic niche, the reversed process takes place (Maren, 2016). This so-called mesenchymal–epithelial transition (MET) returns tumor cells to a high proliferative state and enables the formation of micrometastases (Bakir et al., 2019). TDEs play an important regulatory role in mediating the EMT and MET transformation (Bigagli et al., 2019). There has been increasing research showing the signaling pathway involved in inducing cancer-related EMT. We propose that the critical components in TDEs can serve to promote EMT.

The latest hypothesis is TDEs may be conduits for initiating signals for EMT. For example, TDEs carry EMT derivers, such as transforming growth factor-beta (TGF-β), tumor necrosis factor-alpha (TNF-α), hypoxia-inducible factor 1 alpha (HIF-1α), protein kinase B (AKT), caveolin-1, platelet-derived growth factors (PDGFs), and β-catenin Wnt pathway modulators, that directly enhance the process of EMT (Aga et al., 2014; Kucharzewska et al., 2013; Luga et al., 2012; Ramteke et al., 2015). TDEs transmit non-coding RNA, such as, miR-128-3p, miR-27, LINC00960, linc02470, circ-PVT1, and circ-CPA4, that upregulate EMT (Huang C.-S. et al., 2020; Liu et al., 2019; Wang J. et al., 2018). Therefore, many studies have shown that tumor cells can secrete exosomes into the extracellular space and promote the EMT through their effectors: proteins, miRNAs, circRNAs, and lncRNAs (Figure 2A).

FIGURE 2

FIGURE 2

TDEs enhance the migration ability of tumor cells by promoting EMT and degrading the ECM. (A): Exosomes carry proteins, miRNA, lncRNA, and circRNA to promote the occurrence and development of EMT. (B): TDEs carry proteins or non-coding RNA to initiate degradation of the ECM.

Tumor-Derived Exosomes Promote Extracellular Matrix Degradation

The extracellular matrix (ECM) is a scaffold for tissues and organs (Eble and Niland, 2019). The ECM is a complex network combined with proteins, proteoglycans, and glycoproteins that can regulate cell growth, survival, motility, and differentiation through specific receptors, such as integrin, syndecan, and discoidin receptors (Leitinger, 2011; Xian et al., 2010). Cancer-associated ECM is not only an integral feature of a tumor but also actively contributes to its histopathology and malignant behavior (Levental et al., 2009; Provenzano et al., 2008). From tumor initiation to metastasis, ECM molecules bind with cell surface receptors and activate intracellular signaling pathways. ECM adhesion–induced signals promote self-sufficient growth through mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) (Pylayeva et al., 2009). Focal adhesion kinase (FAK) signaling inhibits p15 and p21, which are growth suppressors, and p53 to limit the induction of apoptosis (Kim et al., 2008). TGF-β and RhoA/Rac signaling promote EMT induction and enhance promigratory pathways (Leight et al., 2012). The ECM can also enhance angiogenesis and strengthen vascular endothelial growth factor (VEGF) signaling in endothelial cells (Liu and Agarwal, 2010).

TDEs mediate tumor–tumor and tumor–host cell crosstalk (Kalluri, 2016). TDEs interact with and regulate the synthesis of ECM components and are involved in ECM remodeling (Rackov et al., 2018). The proteins on the surface of TDEs promote the activation of membrane-associated proteinases, such as Adamts1, Adamts4, and Adamts5, thus improving proteolytic activity (Ginestra et al., 1997; Lo Cicero et al., 2012). In addition, matrix metalloproteinases (MMPs) derived from TDEs participate in localized degradation and ECM proteolysis during cellular migration and metastasis (Ginestra et al., 1997; Atay et al., 2014). However, besides exosomal surface proteins, non-coding RNA also mediates ECM degradation. For example, breast cancer–derived exosomes carry miR-301 to regulate matrix modulation (Morad et al., 2020). Gastric cancer cell–derived exosomal miR-27a reshapes the ECM at adjacent sites and promotes tumor progression by downregulating CSRP2 expression and upregulating α-SMA expression (Wang et al., 2018). Currently, there are no direct reports on other non-coding RNAs, such as lncRNA and cicrRNA, but TDE-derived lncRNA and circRNA can influence fibroblast, chondrocyte, and epithelial cell function, secreting ECM components into the extracellular space (Tan et al., 2020).

Some data suggested that the ECM is a prerequisite for tumor cell invasion and metastasis (Tan et al., 2020). When the tumor cells metastasize, they detach from the ECM. Furthermore, the exosomes participate in this process (Figure 2B).

Tumor-Derived Exosomes Promote Angiogenesis Directly or Indirectly

Regardless of tumor size, metastasis may occur; however, in most cases, metastasis is associated with large primary neoplasms (Fidler and Kripke, 2015). If a tumor mass exceeds 1 mm in diameter, angiogenesis is bound to occur (Folkman, 1971; Nagy and Dvorak, 2012). Therefore, exploring tumor angiogenesis is an important way to understand tumor metastasis.

Tumor-Derived Exosomes Promote Angiogenesis by Activating Macrophages

Cancer-derived exosomes stimulate macrophage infiltration and polarization for establishing a pre-metastatic niche. For example, exosomes derived from CT-26, a colon cancer cell, can provoke macrophages to secrete significantly high levels of monocyte chemoattractant protein-1 (MCP-1) and TNF, thus promoting the growth and migration of colorectal cancer cells. Lung cancer cell–derived exosomes containing miRNA-103 upregulate angiogenic VEGF-A and angiopoietin-1 expression from M2 macrophages (Hsu et al., 2018; Wu et al., 2019). Therefore, TDEs can motivate the angiogenic property of macrophages such as secretion of VEGF (Wu et al., 2019). It can induce angiogenesis by tumor cells. In addition, other immune cells also contribute to tumor angiogenesis, such as neutrophils, myeloid precursor cells (MPCs), and dendritic cells (DCs) (Albini et al., 2018). But, there are no reports about TDE-educated neutrophils, MPCs, or DCs to promote angiogenesis in metastasis.

Tumor-Derived Exosomes Carry Non-coding RNA and Proteins to Promote Angiogenesis Directly

TDEs carry non-coding RNAs, including microRNA, lncRNA, and circRNA, that play an indispensable role in angiogenesis. TDEs carry miR-25-3p that regulates VEGFR2, ZO-1, occludin, and claudin5 expression in ECs by targeting KLF2 and KLF4 and eventually promotes vascular permeability and angiogenesis (Felcht et al., 2012; Wu et al., 2019). TDEs deliver miR-130a to vascular cells to promote angiogenesis by targeting c-MYB (Yang et al., 2018). Exosomal miR-155-5p can induce angiogenesis through the SOCS1/JAK2/STAT3 signaling pathway (Zhou X. et al., 2018). Exosomal miR-135b promotes angiogenesis by inhibiting FOXO1 expression. Exosomal miR-23a induces angiogenesis by targeting TSGA10, prolyl hydroxylase, tight junction protein ZO-1, and SIRT1 (Sruthi et al., 2018; Bai et al., 2019). Exosomal miR-1229 promotes angiogenesis by targeting HIPK2. Exosomal miR-21 promotes angiogenesis by targeting STAT3 (Liu and Cao et al., 2016). In addition, lncRNA containing lncCCAT2, lncMALAT1, lncRNA-p21, and lncPOU3F3 or circRNA, such as TDE-derived circRNA-100338, also promote angiogenesis (Castellano et al., 2020; Huang X.-Y. et al., 2020; Lang, Hu, & Chen et al., 2017; Lang, Hu, &; Zhang Z. et al., 2017; Qiu J.-J. et al., 2018). LncRNA and circRNA are often used as “sponges” to regulate miRNA expression in cells. Moreover, TDEs carry a variety of angiogenic proteins, such as VEGF, IGFBP3, MMP2, ICAM-1, and IL-8, thus enhancing angiogenesis through in vitro and in vivo ligand/receptor signaling (Ludwig and Whiteside, 2018). Therefore, a combination of multiple non-coding RNAs and exosomal proteins promotes tumor angiogenesis.

The importance of angiogenesis in tumor metastasis cannot be understated, TDEs can carry proteins and non-coding RNAs that directly promote angiogenesis or they can mediate angiogenesis indirectly by “educating” macrophages to release proangiogenic factors (Figure 3).

FIGURE 3

FIGURE 3

Exosomes directly or indirectly promote angiogenesis. TDEs promote macrophages to release TNF and VEGF to promote angiogenesis factors by carrying miRNAs or proteins. In addition, TDEs carry proteins, miRNAs, lncRNA, or circRNA to promote angiogenesis directly by targeting endothelial cells.

Tumor-Derived Exosomes can Protect Tumor Cells During Metastasis

Tumor cells shed from primary or secondary tumors are called circulating tumor cells (CTCs) (Paoletti and Hayes, 2016). CTCs invade the bloodstream and attach to the endothelium in the target organ. They then invade the surrounding parenchyma to form new tumors (Garcia et al., 2018). Blood is an unfavorable environment for CTCs, and they struggle with circulating immune cells (Agarwal et al., 2018). TDEs help CTCs metastasize smoothly by inhibiting immune cell activity and conferring a protective layer on them, thus maintaining cellular integrity (Figure 4).

FIGURE 4

FIGURE 4

Role of TDEs in protecting CTCs. TDEs from CTCs and activated platelets suppress NK cell, T cell, and B cell function. In addition, activated platelets can form thrombi that adhere to the surface to protect CTCs.

Tumor-Derived Exosomes can Suppress Immune Cells to Protect CTCs

The immune system inhibits the progression of cancer cells. Many immune cells are found circulating in human blood, including T lymphocytes, natural killer (NK) cells, and B lymphocytes (de la Cruz-Merino et al., 2008; Grivennikov et al., 2010; McCarthy, 2001). These immune cells play crucial roles in immune surveillance, immunosuppression, and killing effects and mainly act on CTCs (Deepak and Acharya, 2010; Pahl and Cerwenka, 2017; Wernersson and Pejler, 2014; Ye et al., 2017). Immune cells can recognize and attack CTCs under normal circumstances; therefore, immunosuppression is necessary for the metastasis of CTCs (Guo et al., 2019). Many researchers have found that TDEs can suppress immune cells. Exosomes carry bioactive molecules that can impair immune cell function (Becker et al., 2016; Kalluri, 2016; Robbins and Morelli, 2014). Programmed cell death receptor ligand 1 (PD-L1) can bind to programmed cell death protein 1 (PD-1) to inactivate T cells through its extracellular domain (L. Chen and Han, 2015; Chen et al., 2015; Garcia-Diaz et al., 2019). TDEs carry PD-L1 on their surface and suppress CD8+ T cell function in metastatic melanoma (Chen et al., 2018). In addition to PD-1, TDEs can also carry others to inhibit T cell function, and prolyl hydroxylase can inhibit CD4+ and CD8+ T cell functions by oxygen sensing (Clever et al., 2016). TDEs block T cell activation and enhance T cell apoptosis (Czernek and Dutchler, 2017; Ludwig et al., 2017). TDEs can also cause NK cell dysfunction. NK cells do not express PD-1; however, TDEs interfere with the TGFβ/TGFβRI/II pathway and other common molecular pathways, such as the adenosine pathway, eventually driving NK cell responses (Hong et al., 2017). In addition, TDEs can inhibit NK cell cytotoxicity by suppressing STAT5 activation (Zhang et al., 2007). B cells play a critical role in immunoglobulin, antigen, and proinflammatory cytokine secretion (Mauri and Bosma, 2012). TDE HMGB1 regulates the proliferation of T cell Ig and mucin domain-1+ (TIM-1+) B cells and fosters cancer cell immune evasion (Ye et al., 2018). We can design therapeutic modalities to enhance immune cell surveillance and killing of these tumors by understanding these signaling pathways.

CTCs Activate Platelets Directly or by Releasing Exosomes

Platelets play major roles in hemostasis and coagulation and regulate the efficiency of canceration, tumor angiogenesis, tumor metastasis, and chemotherapy (Sharma et al., 2014). Platelets and cancer cells interact, thus affecting tumor growth and metastasis (Sharma P. et al., 2018). During blood circulation, other nontumor help is essential, for example, platelets can protect CTCs from blood flow shear forces by providing a protective layer. CTCs release soluble mediators, such as adenosine diphosphate (ADP), thromboxane (TX) A2, or high-mobility group box 1 (HMGB1), that can ligate toll-like receptor 4 (TLR4) to instigate localized platelet activation and form thrombus encasing tumor cells, thus protecting them from cytolysis by NK cells (Aitokallio-Tallberg et al., 1985; Nieswandt et al., 1999; Yu et al., 2014; Zucchella et al., 1989).

The interaction between platelets and CTCs can lead to platelet activation, and platelets release cytokines conducive to the survival and proliferation of tumor cells. When platelets combine with circulating tumor cells, platelet-derived soluble factors (TGF β and PDGF) mediate and prevent NK cells from detecting and dissolving tumor cells (Lambert et al., 2017; Lee J.-K. et al., 2013).

Finally, platelets prevent tumor cells from being eliminated by the immune system. Platelet-derived TGF-β can downregulate NKG2D expression and inactivate NK cells (Y. Chen et al., 2015; Kopp et al., 2009). The platelet expression profile in tumor and nontumor patients varies substantially (Santarpia et al., 2018). The interaction between CTCs and platelets can protect CTCs from immune surveillance during circulation and help tumor cells adhere to the endothelial cells at the metastasis site (Santarpia et al., 2018). Kuznetsov et al. showed that luminal breast cancer cells carried platelets that loaded factors with the effect of pro-inflammatory and pro-angiogenic activities and confirmed that these factors were released at distant tumors sites (Kuznetsov et al., 2012). Platelets are essential for releasing proangiogenic cytokines and recruiting angiogenic vascular endothelial growth factor receptor 2+ (VEGFR2+) cells that promote malignant progression (Schlesinger, 2018). Moreover, studies have shown that platelets may not just have a secondary role but may also drive malignant progression (or metastasis) (Kuo et al., 2011).

In human blood, platelets are considered to be the major contributors of exosomes (Caby et al., 2005). Goetzl et al. showed that endothelial cells absorb platelet-derived exosomes and enhance their adhesion by increasing endothelial cell adhesion protein expression and anti-adhesion factor production, thereby promoting CTC adhesion in vascular endothelial cells (Goetzl et al., 2016). Platelet-derived exosomes also increase platelet adhesion to monocytes and consequently monocyte activation, thus promoting the formation of inflammatory phenotypes (Goetzl et al., 2016).

Therefore, many researchers believe that blood platelets may be a potential source of biomarkers to aid cancer diagnosis. Nonetheless, the mechanism using which CTC-educated platelets mediate CTCs to avoid damage in the circulatory system still needs further research. We firmly believe that these CTC-educated platelet-derived exosomes play an important role in preventing damage to CTCs.

Integrins of Tumor-Derived Exosomes Determine Organotropic Metastasis

That different types of cancer cells preferentially colonize and metastasize to different organs is the salient feature of metastasis (Nguyen et al., 2009). Current research shows that tumors mainly metastasize to lung, brain, lymph node, bone, and liver tissues. We have summarized organotropic metastasis with respect to cancer types (Table 1). Many studies focus on tumor cell adhesion function, and extracellular matrix molecules, such as integrins, have been determined to be related to the choice of organotropic metastasis (Valastyan and Weinberg, 2011).

TABLE 1

Cancer typeOrganotropic metastasisReferences
Acute myeloid leukemiaLiver metastasisWang H. et al. (2020); Wang N. et al. (2020)
Breast cancerBone metastasisSalvador et al. (2019); Tahara et al. (2019); Ma et al. (2020a)
Lung metastasisKim et al. (2018); Yousefi et al. (2018); Tyagi et al. (2021)
Brain metastasisPedrosa et al. (2018); Chang et al. (2020); Hosonaga et al. (2020)
Lymph node metastasisZhang H. et al. (2017); Qiu et al. (2020); Zhang Q. et al. (2017); Xu et al. (2021)
Liver metastasisMa et al. (2015); Yousefi et al. (2018); Bale et al. (2019); Ji et al. (2020)
Bladder cancerBone metastasisFan et al. (2020)
Lymph node metastasisDoshi et al. (2013); Tuncer et al. (2014)
Lung metastasis
Liver metastasis
Mediastinum
Adrenal gland
Colon cancerLiver metastasisYao et al. (2017); Tokoro et al. (2018); Kim et al. (2019a); Li K. et al., (2019); Zhu et al. (2020)
Lung metastasisYao et al. (2017); Tokoro et al. (2018)
Lymph node metastasis(El-Halabi et al. (2014)
Brain metastasisYoshida et al. (2012); Tokoro et al. (2018)
Cervical cancerLung metastasisAli et al. (2017); Chen et al. (2020); Hsieh et al. (2021)
Brain metastasisHwang et al. (2013); Sato et al. (2015); Fetcko et al. (2017); Kim et al. (2019b); Sun et al. (2020)
Lymph node metastasisWu et al. (2020); Zhang C. et al. (2020); Zhang Q. et al. (2020); Zhong et al. (2020)
Bone metastasisYoon et al. (2013); Nartthanarung et al. (2014); Kanayama et al., (2015); Makino et al. (2016)
Liver metastasisNance et al. (2020); Liu et al. (2021)
Gastrointestinal stromal tumorLiver metastasisYamanaka et al. (2013); Yamashita et al. (2016); Cumsille et al. (2019)
Bone metastasisAktan et al. (2015); Suzuki et al. (2015)
Lymph node metastasisCanda et al. (2008); Gong et al. (2011); Kubo and Takeuchi, (2017)
Brain metastasisNaoe et al. (2011)
Lung metastasisXu et al. (2020a); Carvalho et al. (2020)
Gastric cancerLung metastasisQiu et al. (2018a); Wang et al. (2019d); Abe et al. (2020)
Brain metastasisYork et al. (1999); Peng et al. (2014); Yang et al. (2016); Qiu et al., (2018b); Cavanna et al. (2018)
Lymph node metastasisChen et al. (2019); Wang J. et al. (2020); Wang Y. et al. (2020); Kim et al. (2021)
Bone metastasisUbukata et al. (2011); Mikami et al. (2017); Qiu et al. (2018a); Fujita et al. (2020); Imura et al. (2020)
Liver metastasisZhang G. et al. (2017); Qiu et al. (2018b); Luo et al. (2019); Ohara et al. (2020)
GlioblastomaLung metastasisHoffman et al. (2017)
Lymph node metastasisDolman, (1974); Jamjoom et al. (1997); Datta et al. (1998); Alhoulaiby et al. (2020)
Bone metastasisRicard et al. (2019); Nagata et al. (2020)
Liver metastasisYung et al. (1983); Shuto et al. (1995)
Hepatocellular carcinomaBone metastasisZhang et al. (2019b); Park et al. (2019); Ma et al. (2020b); Hu et al. (2020)
Lymph node metastasisXu et al. (2016); Ikegami et al. (2017); Liu et al. (2018a)
Stomach and colonKim et al. (2020)
Brain metastasisYamakawa et al. (2015); Lin et al. (2017); Nam et al. (2019)
Lung metastasisZhang et al. (2019a); Kapoor et al. (2020)
Head and neck cancerLung metastasisNishino et al. (1996); AlShammari et al. (2020)
Brain metastasisNishino et al. (1996); Kofler et al. (2017)
Lymph node metastasisZhou X. et al. (2018); Nienstedt et al. (2018); Zhou Z. et al. (2018); Mermod et al. (2019); Fang et al. (2020); Nishio et al. (2021)
Bone metastasisBhandari and Jain, (2013); Chi et al. (2021)
Liver metastasisChen et al. (2014)
Lung cancerLiver metastasisSridhar et al. (2019); Wang B. et al. (2020); Lu et al. (2020)
Bone metastasisLiu et al. (2017); Okabe et al. (2018); da Silva et al. (2019); Wang et al. (2019b); Ai et al. (2020)
Lymph node metastasisXia et al. (2015); Kong et al. (2017); Wang C.-F. et al. (2020); Wang L. et al. (2020)
Brain metastasisAljohani et al. (2018); Waqar et al. (2018); Wang et al. (2019a); Luo et al. (2020b); Fujimoto et al. (2020)
MelanomaLiver metastasisNakamura et al. (2017a); Ryu et al. (2017); Grossniklaus, (2019); Bustamante et al. (2021)
Bone metastasisUluckan, (2019); Caldaria et al. (2020); Mannavola et al. (2020)
Lymph node metastasisMerkow et al. (2016); Moy et al. (2017); Muhsin-Sharafaldine et al. (2017); Faries et al. (2018); Soler-Cardona et al. (2018)
Brain metastasisKircher et al. (2016); Katona et al. (2017); Redmer, (2018); Schwarz et al. (2019)
Lung metastasisZhu et al. (2016); Hyun et al. (2020); Park et al. (2020); Stansel et al. (2020)
Multiple myeloma (BM-MSC)Liver metastasisEstelles Piera et al. (1993)
MesotheliomaLiver metastasisEtoh et al. (1997); Marzullo et al. (2020)
Bone metastasisLaurini, (1974); Swayne et al. (1992); Roegel et al. (1993); Huang et al. (2019)
Lymph node metastasisSussman and Rosai, (1990); Yan et al. (2006); Abdel Rahman et al. (2008); Takehara et al. (2014)
Brain metastasisAsoh et al. (1990); Kawai et al. (1997); Hirooka et al. (2016)
Ovarian cancerLung metastasisUeda et al. (1973)
Brain metastasisPakneshan et al. (2014); Stasenko et al. (2019)
Lymph node metastasisKleppe et al. (2011); Zhou et al. (2016); Hong et al. (2018); Longo et al. (2020)
Bone metastasisKumar et al. (1992); Tiwari et al. (2007); Zhang and Sun, (2013)
Liver metastasisXu et al. (2017); Wang et al. (2019c); Zhuo et al. (2020)
Pancreatic cancerLung metastasisPark et al. (2017); Sakimura et al. (2019); Uesato et al. (2020)
Brain metastasisMatsumura et al. (2009); Lemke et al. (2013); Matsumoto and Yoshida, (2015); Sasaki et al. (2019)
Lymph node metastasisKanda et al. (2011); Liu et al., 2018b; Ma et al., 2018; Seifert et al. (2020)
Bone metastasisSaif et al. (2010); Guan et al. (2017); Outani et al. (2018)
Liver metastasisHo et al. (2020); Wang et al. (2021a)
Prostate cancerLung metastasisPolistina et al. (2020)
Brain metastasisHernandez-Esquivel et al. (2018); Marchand Crety et al. (2020); Shida et al. (2020)
Lymph node metastasisLi F. et al. (2019); Xu et al. (2020b); Zhao et al. (2020); Klingenberg et al. (2021)
Bone metastasisBerish et al. (2018); Zhang, (2019); Wen et al. (2020)
Liver metastasisSimons et al. (2020); Ma B. et al. (2021)

Chart for organotropic metastasis with respect to cancer types.

Integrins, a large family of adhesion molecules, can mediate cell–cell and cell–extracellular matrix interactions (Desgrosellier and Cheresh, 2010). Many integrins are associated with tumor angiogenesis, such as αvβ3, αvβ5, and α5β1 (Cascone et al., 2005; Lee et al., 2013a; Huang and Rofstad, 2018). β1 integrins bind to vascular cell adhesion molecule 1 (VCAM-1) on ECs and play an important role in trans-endothelial migration (Klemke et al., 2007). Integrins participate in tumor angiogenesis by interacting with the VEGF–VEGFR and ANG–TIE pathways (Klemke et al., 2007). αvβ3 integrin binds to the adhesion molecule L1 on ECs driving trans-endothelial migration (Voura et al., 2001). αvβ3 integrin is the most abundant and influential receptor among integrins on ECs and can regulate angiogenesis (De et al., 2005; Mahabeleshwar et al., 2008; Shattil and Ginsberg, 1997). It can be activated and colocalized with VEGFR-2 on ECs of proliferating blood vessels (Mahabeleshwar et al., 2008). VEGF-stimulated c-Src can be the phosphorylate β3 subunit on ECs, promoting VEGFR-2 phosphorylation and activation (De et al., 2005; Mahabeleshwar et al., 2008; Mahabeleshwar et al., 2007). In addition, αvβ3 is necessary for the survival and maturation of new blood vessels, and proliferative angiogenic EC apoptosis occurs after treatment with αvβ3 antagonists (Brooks et al., 1994). Briefly, integrin subunits α1, α2, α3, α4, α5, α6, α9, αv, β1, β3, and β5 are involved in physiological or pathological angiogenesis. Exosomes affect several steps of angiogenesis including motility, cytokine production, cell adhesion, and cell signaling (Taverna et al., 2012). These can improve the tumor survival environment before metastasis.

Although integrins are secreted by tumor cells, it is transported by exosomes to a distant organ (Peinado et al., 2017). Lyden et al. showed that tumor exosome integrins can determine organotropic metastasis. They suggested that tumor exosome integrins can fuse with organ-specific resident cells and activate Src phosphorylation and proinflammatory S100 expression to establish a pre-metastatic niche (Hoshino et al., 2015). In addition, more bodies of evidence identified that different integrins on the surface of exosomes play varied roles in metastasis to specific organs (Alderton, 2015; Hoshino et al., 2015; Paolillo and Schinelli, 2017). For instance, exosomal integrins α6β4 and α6β1 preferentially direct tumor cells to the lungs, and αvβ5 induces liver metastasis (Hoshino et al., 2015). Tumor exosomes can prepare pre-metastatic niches to facilitate organ-specific metastasis, even for cancer cells equipped to metastasize (Figure 5).

FIGURE 5

FIGURE 5

Choice of metastatic organs. The integrin on the surface of the exosome determines where the tumor metastasizes.

Tumor Cell Growth at the Metastasis Site

Once tumor cells migrate to tissues and organs, TDEs provide them with a good growth environment and the ability to promote their growth.

Tumor-Derived Exosomes Promote Pre-metastatic Niche Formation

A pre-metastasis niche is a primary tumor in secondary organs and tissues that creates a favorable microenvironment for subsequent metastasis. Tumor-derived molecules secreted by primary tumors play a key role in preparing distant sites for the formation of new pre-metastasis niches, promoting metastasis and even determining the orientation of metastatic organs. These major tumor-derived molecules are usually tumor-derived secretory factors, extracellular vesicles (EVs), and other molecular components (Minciacchi et al., 2015). Exosomes containing protein, mRNA, or DNA fragments promote the pre-metastasis niche formation by mediating the communication between tumor cells and surrounding components or transferring their contents to recipient cells (Chin and Wang, 2016; Zhou et al., 2014).

Tumor cells are “seeds”. With tumor-secreting factors, tumor cell–secreting vesicles, and exosomes acting as catalysts, tumor cells can promote the formation of the “soil” (host microenvironment) in a distant metastasis site and promote the growth of cancer cells. Cancer metastasis is preceded by the interaction between the seed and soil (Y. Chen et al., 2015; Lambert et al., 2017; Liu and Cao, 2016; Minciacchi et al., 2015). Primary tumor cells influence and change the microenvironment at secondary organs by promoting pre-metastasis niche factor before tumor cells arrive (Chin and Wang, 2016; He et al., 2017).

The characteristics of a pre-metastasis niche include the following six aspects. First, pre-metastasis niche formation is accompanied by the recruitment of bone marrow–derived cells (BMDC) (Y. Chen et al., 2015; Minciacchi et al., 2015). Literature suggests that extracellular matrix metalloproteinase inducer (EMMPRIN) in cancer cells can induce the secretion and expression of many factors, such as SDF and VEGF, which mediate the recruitment of BMDC to the liver and lungs (Y. Chen et al., 2015; Minciacchi et al., 2015). Second, the immune cells involved in the pre-transfer niche formation are heterogenous. Pre-metastasis niche formation involves not only the recruitment of foreign cells but also the reprogramming of resident stromal cells, promoting metastasis. Pre-metastasis niche formation also involves the change of the ECM. Niche formation before transfer is accompanied by a change in the vascular system. Metastatic breast cancer cells reduce tight junctions between endothelial cells by secreting exosomes containing mir-105, thus inducing systemic vascular leakage and promoting metastasis (Kong et al., 2019). Breast cancer cells secrete exosomes containing miR-122, which are absorbed by niche cells, and reduce glucose consumption by targeting pyruvate kinase, thus increasing the proliferation rate and survival rate of cancer cells and promoting metastasis (Fong et al., 2015). Pancreatic cancer–derived exosomes, rich in macrophage migration inhibitory factors, recruit macrophages and induce pre-metastasis niche formation in the liver (Costa-Silva et al., 2015). Modulation of the pre-metastatic niche formation by controlling TDEs is a new area for future chemotherapy research.

Tumor-Derived Exosomes Promote the Growth of Metastasis Tumor

The growth of metastatic tumors requires suitable “soil”. MET returns the cancer cells to a highly proliferative state but with the loss of their migration characteristics, enabling tumor growth at the metastasis site (Li K. et al., 2019). The characteristics of MET are increased expression of mesenchymal markers, such as vimentin, and decreased expression of epithelial markers, such as E-cadherin, compared with that of EMT (Wells et al., 2008). MET supports the reacquisition of epithelial features to promote metastasis (Brabletz et al., 2001). Several signaling pathways are involved in regulating MET, including transforming growth factor (TGF), fibroblast growth factors (FGFs), bone morphogenic protein (BMP), epidermal growth factor receptor (EGFR), hepatocyte growth factor (HGF), Wnt/β-catenin, and Notch pathways (Said and Williams, 2011). TDEs can support tumor progression and remodel surrounding parenchymal tissues at the metastatic site (Greening et al., 2015). TDEs play an important regulatory role mediating EMT and transforming MET (Bigagli et al., 2019). Gastric cancer cell–derived exosomes can mediate the stimulation of proinflammatory cytokine IL-1β secretion and activate the Akt and MAPK pathways to promote tumor growth at the metastatic site (Che et al., 2018; Wang et al., 2019e). In addition, TDEs can transform stromal cells into tumor-associated stromal cells (TASCs) that can secrete many pro-tumorigenic factors, including IL-6 and IL-8. These factors can enhance the proliferation ability of tumor cells (Bussard et al., 2016). Hence, TDEs can enable tumor cells to acquire proliferation capacity directly through the MET process or promote tumor proliferation by inducing TASC formation and releasing related factors (Figure 6). Nevertheless, there is still a dearth of research on exosomes and their contribution to MET.

FIGURE 6

FIGURE 6

TDEs promote tumor growth at the metastasis site. MET and TASCs promote tumor growth at metastatic sites, and TDEs can derive MET and TASC formation.

Conclusion

Exosomes play an important role in every step leading to tumor metastasis. Although there are many reports on the role of exosomes in metastasis, much is left to be explored of the potential mechanisms underlying metastasis. Although a few studies still have unclear results, we have summarized the published literature on the substances that exosomes carry, their main functions in different tumors, the target cells affected, and steps involved in metastasis. (Table 2). Exploring these underlying mechanisms will enlighten us about cancer biology and contribute to the prevention of and therapeutic strategies for malignancies. We can manipulate TDEs to impede not just metastasis formation but even established metastases.

TABLE 2

Cancer typeExosome componentTarget cellsPotential regulationRoles in metastasis stepsReferences
AMLTGF-βNK cellsNKG2DStep 3: immunosuppressiveSzczepanski et al. (2011)
DPP4Bone-Step 5Namburi et al. (2021)
TGFβ/TGFβRI/IINK-92-Step 3: immunosuppressiveHong et al. (2017)
Breast cancermiR-10bMammary epithelial cellsHOXD10 and KLF4Step 1: enhance invasion abilitySingh et al. (2014)
miR-122Lung fibroblast neuronsPKMStep 2: non-coding RNA influence angiogenesisFong et al. (2015)
RN7SL1Breast cancer cellsPRR RIG-IStep 5Nabet et al. (2017)
miR-200c, miR-141Breast cancer cellsFOXP3-KAT2BEnhance metastasesZhang G. et al. (2017)
miRNA-503Microglia-Step 3: immunosuppressiveXing et al. (2018)
Caveolin-1Breast cancer cells-Enhance metastasesCampos et al. (2018)
miR-193bBreast cancer cellsRAB22AStep 1: enhance invasion abilitySun et al. (2018)
CEMIPBrain endothelial and microglial cells-Step 2: angiogenesisRodrigues et al. (2019)
hsa-miR-940OsteoblasticARHGAP1 and FAM134AStep 5Hashimoto et al. (2018)
miR-126aLungS100A8/A9Step 2Deng et al. (2017)
miR-222Breast cancer cellsNF-κBStep 1Ding et al. (2018)
miR-130a-3pBreast cancer cellsRAB5BStep 1Kong et al. (2018)
miR-939Breast cancer cellsVE-cadherinStep 2: non-coding RNA influence angiogenesisDi Modica et al. (2017)
miR-770TNBCsSTMN1Decrease metastasesLi Y. et al. (2018)
miR-4443Breast cancer cellsTIMP2Step 4Wang H. et al. (2020)
miR-210Endothelial cells-Step 2: non-coding RNA influence angiogenesisKosaka et al. (2013)
miR-1910-3pBreast cancer cellsMTMR3Step 1: enhance invasion abilityWang B. et al. (2020)
miR-146aCAFsTXNIPStep 5Yang et al. (2020b)
miR-4443Liver-Step 1: enhances invasion abilityWang J. et al. (2020)
Bladder CancerLINC02470, LINC00960Bladder cancer cells-Step 1: EMTHuang et al. (2020b)
CMLmiR-92aECIntegrin α5Step 2: non-coding RNA influence angiogenesisUmezu et al. (2014)
Colon cancerhsp 70MDSCSTAT3Step 3: immunosuppressiveChalmin et al. (2010)
KRAS mutationColon CA cells-Step 5: tumor growthDemory Beckler et al. (2013)
TFEC-Step 3: platelet activationGarnier et al. (2012)
miR-193aColon cancer cellsCaprin1Step 5: decrease the growth of cellsTeng et al. (2017)
miR-92a-3pColon cancer cells-Step 1: EMTHu J. L. et al. (2019)
lncRNA H19Colon cancer cellsmiR-141Step 5: METRen et al. (2018)
miR-21-5p; miR-155-5pColon cancer cellsBRG1Step 5Lan et al. (2019)
miR-182-3pColon cancer cellsFOXO4Step 1: EMTLiu et al. (2019)
GDF15HUVECsSmadStep 2Zheng et al. (2020)
MCP-1; TNFMacrophages-Step 2: activating macrophagesChen et al. (2016)
miR-25-3pECsVEGFR, ZO-1, occludin, and claudin5Step 2: angiogenesisZeng et al. (2018)
miR-1229ECsHIPK2Step 2: angiogenesisHu H.-Y. et al. (2019)
Cervical cancerSurvivinCervical cancer cells-Step 5: tumor growth(Khan et al., 2009; Khan et al., 2011)
Cicr-PVT1Cervical cancer cellsMiR-1286Step 1: EMTWang H. et al. (2020)
miR-221-3pHLECVASH1Step 2: Lymphatic vessel formationZhou et al. (2019)
miR-663bCervical cancer cellsMGAT3Step 1: EMTYou et al. (2021b)
GISTKITProgenitor muscle cellsMMP1Step 1: Influence the relationship between tumor cells and cell matrixYou et al. (2021b)
Gastric cancermiR-27aCAFs-Step 1: EMTWang J. et al. (2018)
miR-130aECsC-MYBStep 2: angiogenesisYang et al. (2018)
miR-135bECsFOX1Step 2: angiogenesisBai et al. (2019)
GlioblastomaEGFR vIIIGlioblastoma cellsVEGF, Bcl-x (L), p27Step 5: tumor growthAl-Nedawi et al. (2008)
matrix metalloproteinases, IL-8, PDGFs, and caveolin 1Glioblastoma cellsPI3K/AKTStep 1: EMTKucharzewska et al. (2013)
L1CAMGlioblastoma cellsFAK; FGFREnhance metastasesPace et al. (2019)
miR-148aGlioblastoma cellsCADM1Step 1Cai et al. (2018)
MDA-9/SynteninGlioblastoma cellsCD63-AP-2Step 1Das et al. (2018)
LncRNA CCAT2ECs-Step 2: angiogenesisLang et al. (2017a)
LncRNA POU3F3ECs-Step 2: angiogenesisLang et al. (2017b)
HCCmiR-584, 517c, 378HCC cellsTAK1Step 5: tumor growthKogure et al. (2011)
miR-1247-3pFibroblastsB4GALT3Step 5: TASCsFang T. et al. (2018)
miR-122HCC cellsStep 5: tumor growthQian and Pollard, (2010)
miR-27b-3p/miR-92a-3pHCC cellsIGF1RStep 5: tumor growthBasu and Bhattacharyya et al. (2014)
miR-103ECsVE-cadherinStep 2: non-coding RNA influence angiogenesisBasu and Bhattacharyya et al. (2014), Fang J. H. et al. (2018)
miR-21, miR-10bHCC cells-Step 1Tian et al. (2019)
SMAD3HCC cellsROSStep 4: attachFu et al. (2018)
Step 5: tumor growth
LOXL4HUVECsFAK/SrcStep 2: angiogenesisLi R. et al. (2019)
Vps4AHCC cellsβ-cateninStep 1: EMTHan et al. (2019)
miR-320aHCC cellsCDK2, MMP2Step 1: EMTZhang Z. et al. (2017)
Step 5: TASCs
lncRNA FAL1HCC cellsmiR-1236Enhance metastasesLi B. et al. (2018)
p120-cateninHCC cellsSTAT3Enhance metastasesCheng et al. (2019)
miR-372-3pHCC cellsRab11aEnhance metastasesCao et al. (2019)
Alpha-enolaseHCC cellsIntegrin α6β4Enhance metastasesJiang et al. (2020)
circ_MMP2HCC cellsMMP2Enhance metastasesLiu et al. (2020)
miR-92a-3pHCC cellsPTEN/AktStep 1: EMTLiu et al. (2020)
Linc00161HUVECsmiR-590-3p/ROCKStep 2: angiogenesisYou et al. (2021a)
miR-30a; miR-222HCC cellsMIA3Enhance metastasesDu et al. (2021)
S100A4HCC cellsSTAT3Enhance metastasesSun et al. (2021)
miR-1290ECsSMEK1Step 2: angiogenesisWang et al. (2021b)
circRNA-100338HUVECs-Step 2: angiogenesisHuang et al. (2020b)
TIM11B cellsTLR/MAPKStep 3: immunosuppressiveYe et al. (2018)
HNCFasLT cellsJurkatStep 3: immunosuppressiveKim et al. (2005)
miR-23aHUVECsTSGA10Step 2: angiogenesisBao et al. (2018)
-NK cellsNKG2DStep 3: immunosuppressiveLudwig et al. (2017)
Lung CancermiR-103M2 macrophagesVEGF-AStep 2: angiogenesis(Hsu et al., 2018; Wu et al., 2019)
miR-23aECsZO-1Step 2: angiogenesisHsu et al. (2017)
miR-21HUVECs-Step 2: angiogenesisLiu et al. (2016a)
LncRNA-p21HUVECs-Step 2: angiogenesisCastellano et al. (2020)
MelanomaMETBM progenitor cells-Step 5: tumor growthPeinado et al. (2012)
PD-L1T cellsPD-1Step 3: immunosuppressiveChen et al. (2018)
snRNALung epithelial cellsTLR3Step 5: TASCsLiu et al. (2016b)
CD151Lung, lymph node and stromal cells-Step 4: locationMalla et al. (2018)
FasT cellsMMP9Step 3: immunosuppressiveCai et al. (2012)
miR-191; let-7aMelanoma cells-Step 1: EMTXiao et al. (2016)
Immunomodulatory, proangiogenic factorsMelanoma cells-Step 2: angiogenesisEkstrom et al. (2014)
Step 3: immunosuppressive
HSP70NK cells-Step 3: immunosuppressiveElsner et al. (2007)
uPARHMVECs; ECFCsERK1,2Step 2: angiogenesisBiagioni et al. (2021)
miR-106b-5pMelanoma cellsEphA4Step 5: METLuan et al. (2021)
miR-155-5pCAFsSOCS1/JAK2/STAT3Step 2: angiogenesisZhou X. et al. (2018)
Multiple myeloma (BM-MSC)miR-15aMM cellsFAKStep 1: enhance invasion abilityRoccaro et al. (2013)
miR-let-7cECs-Step 2: TDEs promote angiogenesis by activating macrophagesTian et al. (2021)
miR-135bECHIF-FIHStep 2Umezu et al. (2014)
MesotheliomaTGF-βFibroblastsSMADStep 1: influence the relationship between tumor cells and cell matrixWebber et al. (2010)
NPCHIF1αNPC cellsLMP1Step 1Aga et al. (2014)
miR-23aECTSGA10Step 2: angiogenesisBao et al. (2018)
MMP13NPC cells-Step 1You et al. (2015)
Step 2: angiogenesis
circMYCNPC cells-Enhance metastasesLuo et al. (2020a)
LMP1NPC cells-Step 1: EMTAga et al. (2014)
Ovarian cancerFasLT cellsCD3-zetaStep 3: immunosuppressiveTaylor et al. (2003)
ATF2; MTA1; ROCK1/2HUVECs-Step 2: angiogenesisYi et al. (2015)
GNA12; EPHA2; COIA1MSCs; ECs-Step 5Sharma et al. (2018b)
CD44HPMCs-Step 1Nakamura et al. (2017a)
circWHSC1HPMCsmiR-145; miR-1182Step 2Nakamura et al. (2017b); Zong et al. (2019)
miR-375Ovarian cancer cellsCA-125Enhance metastasesSu et al. (2019)
miR-7EOCEGFR, AKT, ERK1/2Decrease metastasesHu et al. (2017)
LncRNA FAL1Ovarian cancer cellsPTEN/AKTEnhance metastasesHu et al. (2017)
miR-6780b-5pOvarian cancer cells-Step 1: EMTCai et al. (2021)
circRNA051239Ovarian cancer cells-Step 5Ma R. et al. (2021)
LncRNA MALAT1HUVECs-Step 2: angiogenesisQiu et al. (2018a)
Pancreatic cancerMIFLiver Kupfer cells-Step 5: tumor growthCosta-Silva et al. (2015)
miR-301a-3pMacrophagesPTEN/PI3KγStep 2: active macrophagesWang X. et al. (2018)
circ-IARSHUVECs-Enhance metastasesLi J. et al. (2018)
Lin28BCAFslet-7, HMGA2, PDGFBStep 5Zhang et al. (2019c)
miR-501-3pPancreatic ductal adenocarcinomaTGFBR3, TGF-βEnhance metastasesYin et al. (2019)
lncRNA Sox2otPancreatic ductal adenocarcinoma-Step 1: EMTLi Z. et al. (2018)
CD151, Tspan8ASML-Step 1: matrix degradationYue et al. (2015)
miR92a-3pPancreatic ductal adenocarcinomaPTEN/AktStep 1: EMTYang et al. (2020a)
CD44v6/C1QBPPancreatic ductal adenocarcinoma-Step 5Xie et al. (2021)
Prostate cancerαvβ6 IntegrinProstate cancer cells-Step 4Lazaro-Ibanez et al. (2014)
miR-1246Prostate cancer cellsN-cadherin; vimentinStep 1: EMTBhagirath et al. (2018)
miR-940OsteoblasticARHGAP1, FAM134AEnhance metastasesBhagirath et al. (2018)
miR-26aProstate cancer cells-Step 1: EMTWang et al. (2019f)
PKM2BMSCsCXCL12Step 5Dai et al. (2019)
PSGRProstate cancer cells-Step 1: EMTLi et al. (2021)
TGF-β2, TNF1α, IL6, TSG101, Akt, ILK, β-cateninProstate cancer cells-Step 1: matrix degradationRamteke et al. (2015)

Role and target of the components of TDEs in tumor metastasis.

The role of exosomes in various cancer metastases. AML: acute myeloid leukemia. CML: chronic myeloid leukemia. GIST: gastrointestinal stromal tumor. HCC: hepatocellular carcinoma. HNC: head and neck cancer. NPC: nasopharyngeal carcinoma.

Statements

Author contributions

SB and ZW developed the first draft of the manuscript. All authors contributed to the planning, organization, data collection, and writing of the manuscript. JD completed all figures and provided critical edits. The final version of the manuscript was approved by all authors.

Funding

The study was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81972539 and U1732157).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1

    Abdel RahmanA. R. M.GaafarR. M.BakiH. A.El HosienyH. M.AboulkasemF.FarahatE. G.et al (2008). Prevalence and Pattern of Lymph Node Metastasis in Malignant Pleural Mesothelioma. Ann. Thorac. Surg.86 (2), 391395. 10.1016/j.athoracsur.2008.04.012

  • 2

    AbeY.SuzukiM.TsujiK.SatoM.KimuraH.KimuraH.et al (2020). Lung Metastasis from Gastric Cancer Presenting as Diffuse Ground-Glass Opacities. Respir. Med. Case Rep.30, 101104. 10.1016/j.rmcr.2020.101104

  • 3

    AgaM.BentzG. L.RaffaS.TorrisiM. R.KondoS.WakisakaN.et al (2014). Exosomal HIF1α Supports Invasive Potential of Nasopharyngeal Carcinoma-Associated LMP1-Positive Exosomes. Oncogene33 (37), 46134622. 10.1038/onc.2014.66

  • 4

    AgarwalA.BalicM.El-AshryD.CoteR. J. (2018). Circulating Tumor Cells. Cancer J.24 (2), 7077. 10.1097/PPO.0000000000000310

  • 5

    AiC.MaG.DengY.ZhengQ.GenY.LiW.et al (2020). Nm23‐H1 Inhibits Lung Cancer Bone‐specific Metastasis by Upregulating miR‐660‐5p Targeted SMARCA5. Thorac. Cancer11 (3), 640650. 10.1111/1759-7714.13308

  • 6

    Aitokallio-TallbergA.KärkkäinenJ.PantzarP.WahlströmT.YlikorkalaO. (1985). Prostacyclin and Thromboxane in Breast Cancer: Relationship between Steroid Receptor Status and Medroxyprogesterone Acetate. Br. J. Cancer51 (5), 671674. 10.1038/bjc.1985.101

  • 7

    AktanM.KocM.YavuzB. B.KanyilmazG. (2015). Two Cases of Gastrointestinal Stromal Tumor of the Small Intestine with Liver and Bone Metastasis. Ann. Transl Med.3 (17), 259. 10.3978/j.issn.2305-5839.2015.09.46

  • 8

    Al-NedawiK.MeehanB.MicallefJ.LhotakV.MayL.GuhaA.et al (2008). Intercellular Transfer of the Oncogenic Receptor EGFRvIII by Microvesicles Derived from Tumour Cells. Nat. Cel Biol10 (5), 619624. 10.1038/ncb1725

  • 9

    AlbiniA.BrunoA.NoonanD. M.MortaraL. (2018). Contribution to Tumor Angiogenesis from Innate Immune Cells within the Tumor Microenvironment: Implications for Immunotherapy. Front. Immunol.9, 527. 10.3389/fimmu.2018.00527

  • 10

    AldertonG. K. (2015). Directions to Metastatic Sites. Nat. Rev. Cancer15 (12), 696697. 10.1038/nrc4046

  • 11

    AlhoulaibyS.AbdulrahmanA.AlouniG.MahfoudM.ShihabiZ. (2020). Extra‐CNS Metastasis of Glioblastoma Multiforme to Cervical Lymph Nodes and Parotid Gland: A Case Report. Clin. Case Rep.8 (9), 16721677. 10.1002/ccr3.2985

  • 12

    AliA.KimS. H.KimM. J.ChoiM. Y.KangS. S.ChoG. J.et al (2017). O-GlcNAcylation of NF-kappaB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression. Mol. Cell40 (7), 476484. 10.14348/molcells.2017.2309

  • 13

    AljohaniH. M.AittalebM.FurgasonJ. M.AmayaP.DeebA.ChalmersJ. J.et al (2018). Genetic Mutations Associated with Lung Cancer Metastasis to the Brain. Mutagenesis33 (2), 137145. 10.1093/mutage/gey003

  • 14

    AlShammariA.AlmasriT.SarrajJ.AlAshgarO.AhmedM. H.AlKattanK.et al (2020). Pulmonary Metastasis of Head and Neck Cancer: Surgical Removal Outcomes from a Tertiary Care center. Indian J. Thorac. Cardiovasc. Surg.36 (3), 199206. 10.1007/s12055-019-00866-3

  • 15

    AsohY.NakamuraM.MaedaT.ShiogaiT.OgashiwaM.TakeuchiK.et al (1990). Brain Metastasis from Primary Pericardial Mesothelioma. Neurol. Med. Chir.(Tokyo)30 (11 Spec No), 884887. 10.2176/nmc.30.884

  • 16

    AtayS.BanskotaS.CrowJ.SethiG.RinkL.GodwinA. K. (2014). Oncogenic KIT-Containing Exosomes Increase Gastrointestinal Stromal Tumor Cell Invasion. Proc. Natl. Acad. Sci.111 (2), 711716. 10.1073/pnas.1310501111

  • 17

    BaiM.LiJ.YangH.ZhangH.ZhouZ.DengT.et al (2019). miR-135b Delivered by Gastric Tumor Exosomes Inhibits FOXO1 Expression in Endothelial Cells and Promotes Angiogenesis. Mol. Ther.27 (10), 17721783. 10.1016/j.ymthe.2019.06.018

  • 18

    BakirB.ChiarellaA. M.PitarresiJ. R.RustgiA. K. (2020). EMT, MET, Plasticity, and Tumor Metastasis. Trends Cel Biol.30 (10), 764776. 10.1016/j.tcb.2020.07.003

  • 19

    BalajL.LessardR.DaiL.ChoY.-J.PomeroyS. L.BreakefieldX. O.et al (2011). Tumour Microvesicles Contain Retrotransposon Elements and Amplified Oncogene Sequences. Nat. Commun.2, 180. 10.1038/ncomms1180

  • 20

    BaleR.PutzerD.SchullianP. (2019). Local Treatment of Breast Cancer Liver Metastasis. Cancers11 (9), 1341. 10.3390/cancers11091341

  • 21

    BaoL.YouB.ShiS.ShanY.ZhangQ.YueH.et al (2018). Metastasis-associated miR-23a from Nasopharyngeal Carcinoma-Derived Exosomes Mediates Angiogenesis by Repressing a Novel Target Gene TSGA10. Oncogene37 (21), 28732889. 10.1038/s41388-018-0183-6

  • 22

    BasuS.BhattacharyyaS. N. (2014). Insulin-like Growth Factor-1 Prevents miR-122 Production in Neighbouring Cells to Curtail its Intercellular Transfer to Ensure Proliferation of Human Hepatoma Cells. Nucleic Acids Res.42 (11), 71707185. 10.1093/nar/gku346

  • 23

    BeckerA.ThakurB. K.WeissJ. M.KimH. S.PeinadoH.LydenD. (2016). Extracellular Vesicles in Cancer: Cell-To-Cell Mediators of Metastasis. Cancer Cell30 (6), 836848. 10.1016/j.ccell.2016.10.009

  • 24

    BerishR. B.AliA. N.TelmerP. G.RonaldJ. A.LeongH. S. (2018). Translational Models of Prostate Cancer Bone Metastasis. Nat. Rev. Urol.15 (7), 403421. 10.1038/s41585-018-0020-2

  • 25

    BhagirathD.YangT. L.BucayN.SekhonK.MajidS.ShahryariV.et al (2018). microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer. Cancer Res.78 (7), 18331844. 10.1158/0008-5472.CAN-17-2069

  • 26

    BhandariV.JainR. (2013). A Retrospective Study of Incidence of Bone Metastasis in Head and Neck Cancer. J. Can. Res. Ther.9 (1), 9093. 10.4103/0973-1482.110385

  • 27

    BiagioniA.LaurenzanaA.MenicacciB.PeppicelliS.AndreucciE.BianchiniF.et al (2021). uPAR-Expressing Melanoma Exosomes Promote Angiogenesis by VE-Cadherin, EGFR and uPAR Overexpression and Rise of ERK1,2 Signaling in Endothelial Cells. Cell. Mol. Life Sci.78 (6), 30573072. 10.1007/s00018-020-03707-4

  • 28

    BigagliE.CinciL.D'AmbrosioM.LuceriC. (2019). Transcriptomic Characterization, Chemosensitivity and Regulatory Effects of Exosomes in Spontaneous EMT/MET Transitions of Breast Cancer Cells. Cancer Genomics Proteomics16 (3), 163173. 10.21873/cgp.20122

  • 29

    BrabletzT.JungA.ReuS.PorznerM.HlubekF.Kunz-SchughartL. A.et al (2001). Variable -catenin Expression in Colorectal Cancers Indicates Tumor Progression Driven by the Tumor Environment. Proc. Natl. Acad. Sci.98 (18), 1035610361. 10.1073/pnas.171610498

  • 30

    BrooksP. C.MontgomeryA. M. P.RosenfeldM.ReisfeldR. A.HuT.KlierG.et al (1994). Integrin αvβ3 Antagonists Promote Tumor Regression by Inducing Apoptosis of Angiogenic Blood Vessels. Cell79 (7), 11571164. 10.1016/0092-8674(94)90007-8

  • 31

    BussardK. M.MutkusL.StumpfK.Gomez-ManzanoC.MariniF. C. (2016). Tumor-associated Stromal Cells as Key Contributors to the Tumor Microenvironment. Breast Cancer Res.18 (1), 84. 10.1186/s13058-016-0740-2

  • 32

    BustamanteP.PiquetL.LandrevilleS.BurnierJ. V. (2021). Uveal Melanoma Pathobiology: Metastasis to the Liver. Semin. Cancer Biol.71, 6585. 10.1016/j.semcancer.2020.05.003

  • 33

    CabyM.-P.LankarD.Vincendeau-ScherrerC.RaposoG.BonnerotC. (2005). Exosomal-like Vesicles Are Present in Human Blood Plasma. Int. Immunol.17 (7), 879887. 10.1093/intimm/dxh267

  • 34

    CaiJ.GongL.LiG.GuoJ.YiX.WangZ. (2021). Exosomes in Ovarian Cancer Ascites Promote Epithelial-Mesenchymal Transition of Ovarian Cancer Cells by Delivery of miR-6780b-5p. Cell Death Dis12 (2), 210. 10.1038/s41419-021-03490-5

  • 35

    CaiQ.ZhuA.GongL. (2018). Exosomes of Glioma Cells Deliver miR-148a to Promote Proliferation and Metastasis of Glioblastoma via Targeting CADM1. Bull. du Cancer105 (7-8), 643651. 10.1016/j.bulcan.2018.05.003

  • 36

    CaiZ.YangF.YuL.YuZ.JiangL.WangQ.et al (2012). Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway. J.I.188 (12), 59545961. 10.4049/jimmunol.1103466

  • 37

    CaldariaA.GiuffridaR.di MeoN.MassariL.DianzaniC.CannavòS. P.et al (2020). Diagnosis and Treatment of Melanoma Bone Metastasis: A Multidisciplinary Approach. Dermatol. Ther.33 (6), e14193. 10.1111/dth.14193

  • 38

    CamposA.SalomonC.BustosR.DíazJ.MartínezS.SilvaV.et al (2018). Caveolin-1-containing Extracellular Vesicles Transport Adhesion Proteins and Promote Malignancy in Breast Cancer Cell Lines. Nanomedicine13 (20), 25972609. 10.2217/nnm-2018-0094

  • 39

    CandaA. E.OzsoyY.NalbantO. A.SagolO. (2008). Gastrointestinal Stromal Tumor of the Stomach with Lymph Node Metastasis. World J. Surg. Onc6, 97. 10.1186/1477-7819-6-97

  • 40

    CaoS.-Q.ZhengH.SunB.-C.WangZ.-L.LiuT.GuoD.-H.et al (2019). Long Non-coding RNA Highly Up-Regulated in Liver Cancer Promotes Exosome Secretion. Wjg25 (35), 52835299. 10.3748/wjg.v25.i35.5283

  • 41

    CarvalhoJ.TeixeiraM.SilvaF. T.EstevesA.RibeiroC.GuerraD. (2020). Esophageal Gastrointestinal Stromal Tumor with Rare Intracranial Metastasis. Case Rep. Gastrointest. Med.2020, 14. 10.1155/2020/8842006

  • 42

    CasconeI.NapioneL.ManieroF.SeriniG.BussolinoF. (2005). Stable Interaction between α5β1 Integrin and Tie2 Tyrosine Kinase Receptor Regulates Endothelial Cell Response to Ang-1. J. Cel Biol170 (6), 9931004. 10.1083/jcb.200507082

  • 43

    CastellanoJ. J.MarradesR. M.MolinsL.ViñolasN.MoisesJ.CanalsJ.et al (2020). Extracellular Vesicle lincRNA-P21 Expression in Tumor-Draining Pulmonary Vein Defines Prognosis in NSCLC and Modulates Endothelial Cell Behavior. Cancers12 (3), 734. 10.3390/cancers12030734

  • 44

    CavannaL.SeghiniP.Di NunzioC.OrlandiE.MichielettiE.StroppaE.et al (2018). Gastric Cancer with Brain Metastasis and the Role of Human Epidermal Growth Factor 2 Status. Oncol. Lett.15 (4), 57875791. 10.3892/ol.2018.8054

  • 45

    ChalminF.LadoireS.MignotG.VincentJ.BruchardM.Remy-MartinJ.-P.et al (2010). Membrane-associated Hsp72 from Tumor-Derived Exosomes Mediates STAT3-dependent Immunosuppressive Function of Mouse and Human Myeloid-Derived Suppressor Cells. J. Clin. Invest.120 (2), 457471. 10.1172/JCI40483

  • 46

    ChangG.ShiL.YeY.ShiH.ZengL.TiwaryS.et al (2020). YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. Cancer Cell38 (6), 857871. 10.1016/j.ccell.2020.10.004

  • 47

    CheY.GengB.XuY.MiaoX.ChenL.MuX.et al (2018). Helicobacter pylori -induced Exosomal MET Educates Tumour-Associated Macrophages to Promote Gastric Cancer Progression. J. Cel Mol Med22 (11), 57085719. 10.1111/jcmm.13847

  • 48

    ChenD.ChenG.JiangW.FuM.LiuW.SuiJ.et al (2019). Association of the Collagen Signature in the Tumor Microenvironment with Lymph Node Metastasis in Early Gastric Cancer. JAMA Surg.154 (3), e185249. 10.1001/jamasurg.2018.5249

  • 49

    ChenG.HuangA. C.ZhangW.ZhangG.WuM.XuW.et al (2018). Exosomal PD-L1 Contributes to Immunosuppression and Is Associated with Anti-PD-1 Response. Nature560 (7718), 382386. 10.1038/s41586-018-0392-8

  • 50

    ChenL.HanX. (2015). Anti-PD-1/PD-L1 Therapy of Human Cancer: Past, Present, and Future. J. Clin. Invest.125 (9), 33843391. 10.1172/JCI80011

  • 51

    ChenP. G.SchoeffS. S.WattsC. A.ReibelJ. F.LevineP. A.ShonkaD. C.Jr.et al (2014). Utility of Abdominal Imaging to Assess for Liver Metastasis in Patients with Head and Neck Cancer and Abnormal Liver Function Tests. Am. J. Otolaryngol.35 (2), 137140. 10.1016/j.amjoto.2013.10.004

  • 52

    ChenX.ChenL.ZhuH.TaoJ. (2020). Risk Factors and Prognostic Predictors for Cervical Cancer Patients with Lung Metastasis. J. Cancer11 (20), 58805889. 10.7150/jca.46258

  • 53

    ChenY.GouX.KongD. K.WangX.WangJ.ChenZ.et al (2015). EMMPRIN Regulates Tumor Growth and Metastasis by Recruiting Bone Marrow-Derived Cells through Paracrine Signaling of SDF-1 and VEGF. Oncotarget6 (32), 3257532585. 10.18632/oncotarget.5331

  • 54

    ChenZ.YangL.CuiY.ZhouY.YinX.GuoJ.et al (2016). Cytoskeleton-centric Protein Transportation by Exosomes Transforms Tumor-Favorable Macrophages. Oncotarget7 (41), 6738767402. 10.18632/oncotarget.11794

  • 55

    ChengZ.LeiZ.YangP.SiA.XiangD.TangX.et al (2019). Exosome‐transmitted P120‐catenin Suppresses Hepatocellular Carcinoma Progression via STAT3 Pathways. Mol. Carcinog58 (8), 13891399. 10.1002/mc.23022

  • 56

    ChiC.FanZ.YangB.SunH.ZhengZ. (2021). The Clinical Characteristics and Prognostic Nomogram for Head and Neck Cancer Patients with Bone Metastasis. J. Oncol.2021, 112. 10.1155/2021/5859757

  • 57

    ChinA. R.WangS. E. (2016). Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications. Clin. Cancer Res.22 (15), 37253733. 10.1158/1078-0432.CCR-16-0028

  • 58

    ChoiD.-S.KimD.-K.KimY.-K.GhoY. S. (2013). Proteomics, Transcriptomics and Lipidomics of Exosomes and Ectosomes. Proteomics13 (10-11), 15541571. 10.1002/pmic.201200329

  • 59

    CleverD.RoychoudhuriR.ConstantinidesM. G.AskenaseM. H.SukumarM.KlebanoffC. A.et al (2016). Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche. Cell166 (5), 11171131 e1114. 10.1016/j.cell.2016.07.032

  • 60

    Costa-SilvaB.AielloN. M.OceanA. J.SinghS.ZhangH.ThakurB. K.et al (2015). Pancreatic Cancer Exosomes Initiate Pre-metastatic Niche Formation in the Liver. Nat. Cel Biol17 (6), 816826. 10.1038/ncb3169

  • 61

    CumsilleP.GodoyM.GerdtzenZ. P.ConcaC. (2019). Parameter Estimation and Mathematical Modeling for the Quantitative Description of Therapy Failure Due to Drug Resistance in Gastrointestinal Stromal Tumor Metastasis to the Liver. PLoS One14 (5), e0217332. 10.1371/journal.pone.0217332

  • 62

    CzernekL.DüchlerM. (2017). Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression. Arch. Immunol. Ther. Exp.65 (4), 311323. 10.1007/s00005-016-0453-3

  • 63

    da SilvaG. T.BergmannA.ThulerL. C. S. (2019). Incidence and Risk Factors for Bone Metastasis in Non-small Cell Lung Cancer. Asian Pac. J. Cancer Prev.20 (1), 4551. 10.31557/APJCP.2019.20.1.45

  • 64

    DaiJ.Escara-WilkeJ.KellerJ. M.JungY.TaichmanR. S.PientaK. J.et al (2019). Primary Prostate Cancer Educates Bone Stroma through Exosomal Pyruvate Kinase M2 to Promote Bone Metastasis. J. Exp. Med.216 (12), 28832899. 10.1084/jem.20190158

  • 65

    DasS. K.PradhanA. K.BhoopathiP.TalukdarS.ShenX.-N.SarkarD.et al (2018). The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion. Cancer Res.78 (11), 28522863. 10.1158/0008-5472.CAN-17-2992

  • 66

    DattaC. K.WeinsteinJ. D.BlandJ. E.BragerP. M.StewartM. A. (1998). A Case of Cervical Lymph Node Metastasis Resulting from Glioblastoma Multiforme. W V Med. J.94 (5), 276278.

  • 67

    de la Cruz-MerinoL.Grande-PulidoE.Albero-TamaritA.Codes-Manuel de VillenaM. E. (2008). Cancer and Immune Response: Old and New Evidence for Future Challenges. Oncologist13 (12), 12461254. 10.1634/theoncologist.2008-0166

  • 68

    DeS.RazorenovaO.McCabeN. P.O'TooleT.QinJ.ByzovaT. V. (2005). VEGF-integrin Interplay Controls Tumor Growth and Vascularization. Proc. Natl. Acad. Sci.102 (21), 75897594. 10.1073/pnas.0502935102

  • 69

    DeepakP.AcharyaA. (2010). Anti-tumor Immunity and Mechanism of Immunosuppression Mediated by Tumor Cells: Role of Tumor-Derived Soluble Factors and Cytokines. Int. Rev. Immunol.29 (4), 421458. 10.3109/08830185.2010.483027

  • 70

    Demory BecklerM.HigginbothamJ. N.FranklinJ. L.HamA.-J.HalveyP. J.ImasuenI. E.et al (2013). Proteomic Analysis of Exosomes from Mutant KRAS colon Cancer Cells Identifies Intercellular Transfer of Mutant KRAS. Mol. Cell Proteomics12 (2), 343355. 10.1074/mcp.M112.022806

  • 71

    DengZ.RongY.TengY.ZhuangX.SamykuttyA.MuJ.et al (2017). Exosomes miR-126a Released from MDSC Induced by DOX Treatment Promotes Lung Metastasis. Oncogene36 (5), 639651. 10.1038/onc.2016.229

  • 72

    DesgrosellierJ. S.ChereshD. A. (2010). Integrins in Cancer: Biological Implications and Therapeutic Opportunities. Nat. Rev. Cancer10 (1), 922. 10.1038/nrc2748

  • 73

    DeyM.FetckoK.GondimD.BonninJ. (2017). Cervical Cancer Metastasis to the Brain: A Case Report and Review of Literature. Surg. Neurol. Int.8, 181. 10.4103/sni.sni_111_17

  • 74

    Di ModicaM.RegondiV.SandriM.IorioM. V.ZanettiA.TagliabueE.et al (2017). Breast Cancer-Secreted miR-939 Downregulates VE-Cadherin and Destroys the Barrier Function of Endothelial Monolayers. Cancer Lett.384, 94100. 10.1016/j.canlet.2016.09.013

  • 75

    DiepenbruckM.ChristoforiG. (2016). Epithelial-mesenchymal Transition (EMT) and Metastasis: Yes, No, Maybe?Curr. Opin. Cel Biol.43, 713. 10.1016/j.ceb.2016.06.002

  • 76

    DingJ.XuZ.ZhangY.TanC.HuW.WangM.et al (2018). Exosome-mediated miR-222 Transferring: An Insight into NF-Κb-Mediated Breast Cancer Metastasis. Exp. Cel Res.369 (1), 129138. 10.1016/j.yexcr.2018.05.014

  • 77

    DolmanC. L. (1974). Lymph Node Metastasis as First Manifestation of Glioblastoma. J. Neurosurg.41 (5), 607609. 10.3171/jns.1974.41.5.0607

  • 78

    DoshiT. V.DoshiJ. V.MakaryusJ. N.MakaryusA. N. (2013). A Rare Case of Successfully Treated Cardiac Metastasis from Transitional Cell Bladder Cancer. Am. J. Ther.20 (3), 307310. 10.1097/MJT.0b013e3181f6c131

  • 79

    DuQ.YeX.LuS.-R.LiH.LiuH.-Y.ZhaiQ.et al (2021). Exosomal miR-30a and miR-222 Derived from colon Cancer Mesenchymal Stem Cells Promote the Tumorigenicity of colon Cancer through Targeting MIA3. J. Gastrointest. Oncol.12 (1), 5268. 10.21037/jgo-20-513

  • 80

    EbleJ. A.NilandS. (2019). The Extracellular Matrix in Tumor Progression and Metastasis. Clin. Exp. Metastasis36 (3), 171198. 10.1007/s10585-019-09966-1

  • 81

    EkströmE. J.BergenfelzC.von BülowV.SeriflerF.CarlemalmE.JönssonG.et al (2014). WNT5A Induces Release of Exosomes Containing Pro-angiogenic and Immunosuppressive Factors from Malignant Melanoma Cells. Mol. Cancer13, 88. 10.1186/1476-4598-13-88

  • 82

    El-HalabiM. M.ChaabanS. A.MeouchyJ.PageS.SalyersW. J.Jr. (2014). Colon Cancer Metastasis to Mediastinal Lymph Nodes without Liver or Lung Involvement: A Case Report. Oncol. Lett.8 (5), 22212224. 10.3892/ol.2014.2426

  • 83

    ElsnerL.MuppalaV.GehrmannM.LozanoJ.MalzahnD.BickeböllerH.et al (2007). The Heat Shock Protein HSP70 Promotes Mouse NK Cell Activity against Tumors that Express Inducible NKG2D Ligands. J. Immunol.179 (8), 55235533. 10.4049/jimmunol.179.8.5523

  • 84

    Estelles PieraF.Peris GodoyM.Saro PérezE.Calabuig AlborchJ. R. (1993). Multiple Myeloma and Adenocarcinoma Liver Metastasis. Med. Interna10 (7), 363.

  • 85

    EtohT.BabaH.AdachiE.KohnoeS.SeoY.SaitoT.et al (1997). A Case of Liver Metastasis of Malignant Peritoneal Mesothelioma Successfully Treated by Surgery. Oncol. Rep.4 (4), 803805. 10.3892/or.4.4.803

  • 86

    FanZ.HuangZ.HuC.TongY.ZhaoC. (2020). Risk Factors and Nomogram for Newly Diagnosis of Bone Metastasis in Bladder Cancer. Medicine (Baltimore)99 (42), e22675. 10.1097/MD.0000000000022675

  • 87

    FangJ. H.ZhangZ. J.ShangL. R.LuoY. W.LinY. F.YuanY.et al (2018). Hepatoma Cell‐secreted Exosomal microRNA‐103 Increases Vascular Permeability and Promotes Metastasis by Targeting junction Proteins. Hepatology68 (4), 14591475. 10.1002/hep.29920

  • 88

    FangT.LvH.LvG.LiT.WangC.HanQ.et al (2018). Tumor-derived Exosomal miR-1247-3p Induces Cancer-Associated Fibroblast Activation to foster Lung Metastasis of Liver Cancer. Nat. Commun.9 (1), 191. 10.1038/s41467-017-02583-0

  • 89

    FangW.-Y.KuoY.-Z.ChangJ.-Y.HsiaoJ.-R.KaoH.-Y.TsaiS.-T.et al (2020). The Tumor Suppressor TGFBR3 Blocks Lymph Node Metastasis in Head and Neck Cancer. Cancers12 (6), 1375. 10.3390/cancers12061375

  • 90

    FariesM. B.HanD.ReintgenM.KerivanL.ReintgenD.CaracòC. (2018). Lymph Node Metastasis in Melanoma: a Debate on the Significance of Nodal Metastases, Conditional Survival Analysis and Clinical Trials. Clin. Exp. Metastasis35 (5-6), 431442. 10.1007/s10585-018-9898-6

  • 91

    FelchtM.LuckR.ScheringA.SeidelP.SrivastavaK.HuJ.et al (2012). Angiopoietin-2 Differentially Regulates Angiogenesis through TIE2 and Integrin Signaling. J. Clin. Invest.122 (6), 19912005. 10.1172/JCI58832

  • 92

    FidlerI. J.KripkeM. L. (2015). The challenge of Targeting Metastasis. Cancer Metastasis Rev.34 (4), 635641. 10.1007/s10555-015-9586-9

  • 93

    FongM. Y.ZhouW.LiuL.AlontagaA. Y.ChandraM.AshbyJ.et al (2015). Breast-cancer-secreted miR-122 Reprograms Glucose Metabolism in Premetastatic Niche to Promote Metastasis. Nat. Cel Biol17 (2), 183194. 10.1038/ncb3094

  • 94

    FuQ.ZhangQ.LouY.YangJ.NieG.ChenQ.et al (2018). Primary Tumor-Derived Exosomes Facilitate Metastasis by Regulating Adhesion of Circulating Tumor Cells via SMAD3 in Liver Cancer. Oncogene37 (47), 61056118. 10.1038/s41388-018-0391-0

  • 95

    FujimotoT.NakagawaS.MorofujiY.WatanabeD.UjifukuK.HorieN.et al (2020). Pericytes Suppress Brain Metastasis from Lung Cancer In Vitro. Cell Mol Neurobiol40 (1), 113121. 10.1007/s10571-019-00725-0

  • 96

    FujitaI.ToyokawaT.MakinoT.MatsuedaK.OmoteS.HoriiJ. (2020). Small Early Gastric Cancer with Synchronous Bone Metastasis: A Case Report. Mol. Clin. Onc12 (3), 202207. 10.3892/mco.2020.1985

  • 97

    GarcíaS. A.WeitzJ.SchölchS. (2018). Circulating Tumor Cells. Methods Mol. Biol.1692, 213219. 10.1007/978-1-4939-7401-6_18

  • 98

    Garcia-DiazA.ShinD. S.MorenoB. H.SacoJ.Escuin-OrdinasH.RodriguezG. A.et al (2019). Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression. Cel Rep.29 (11), 3766. 10.1016/j.celrep.2019.11.113

  • 99

    GarnierD.MagnusN.LeeT. H.BentleyV.MeehanB.MilsomC.et al (2012). Cancer Cells Induced to Express Mesenchymal Phenotype Release Exosome-like Extracellular Vesicles Carrying Tissue Factor. J. Biol. Chem.287 (52), 4356543572. 10.1074/jbc.M112.401760

  • 100

    GinestraA.MoneaS.SeghezziG.DoloV.NagaseH.MignattiP.et al (1997). Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells. J. Biol. Chem.272 (27), 1721617222. 10.1074/jbc.272.27.17216

  • 101

    GoetzlE. J.GoetzlL.KarlinerJ. S.TangN.PulliamL. (2016). Human Plasma Platelet‐derived Exosomes: Effects of Aspirin. FASEB j.30 (5), 20582063. 10.1096/fj.201500150R

  • 102

    GreeningD. W.GopalS. K.XuR.SimpsonR. J.ChenW. (2015). Exosomes and Their Roles in Immune Regulation and Cancer. Semin. Cel Dev. Biol.40, 7281. 10.1016/j.semcdb.2015.02.009

  • 103

    GrivennikovS. I.GretenF. R.KarinM. (2010). Immunity, Inflammation, and Cancer. Cell140 (6), 883899. 10.1016/j.cell.2010.01.025

  • 104

    GrossniklausH. E. (2019). Understanding Uveal Melanoma Metastasis to the Liver: The Zimmerman Effect and the Zimmerman Hypothesis. Ophthalmology126 (4), 483487. 10.1016/j.ophtha.2018.09.031

  • 105

    GuanZ.LanH.ChenX.JiangX.WangX.JinK. (2017). Individualized Drug Screening Based on Next Generation Sequencing and Patient Derived Xenograft Model for Pancreatic Cancer with Bone Metastasis. Mol. Med. Rep.16 (4), 47844790. 10.3892/mmr.2017.7213

  • 106

    GuoY.JiX.LiuJ.FanD.ZhouQ.ChenC.et al (2019). Effects of Exosomes on Pre-metastatic Niche Formation in Tumors. Mol. Cancer18 (1), 39. 10.1186/s12943-019-0995-1

  • 107

    HanQ.LvL.WeiJ.LeiX.LinH.LiG.et al (2019). Vps4A Mediates the Localization and Exosome Release of β-catenin to Inhibit Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Cancer Lett.457, 4759. 10.1016/j.canlet.2019.04.035

  • 108

    HashimotoK.OchiH.SunamuraS.KosakaN.MabuchiY.FukudaT.et al (2018). Cancer-secreted Hsa-miR-940 Induces an Osteoblastic Phenotype in the Bone Metastatic Microenvironment via Targeting ARHGAP1 and FAM134A. Proc. Natl. Acad. Sci. USA115 (9), 22042209. 10.1073/pnas.1717363115

  • 109

    HeJ.ShiJ.ZhangK.XueJ.LiJ.YangJ.et al (2017). Sox2 Inhibits Wnt-β-Catenin Signaling and Metastatic Potency of Cisplatin-Resistant Lung Adenocarcinoma Cells. Mol. Med. Rep.15 (4), 16931701. 10.3892/mmr.2017.6170

  • 110

    Hernández-EsquivelM. A.Pérez-TorresA.Romero-RomeroL.Reyes-MatuteA.LoaizaB.Mellado-SánchezG.et al (2018). The Dialyzable Leukocyte Extract TransferonTM Inhibits Tumor Growth and Brain Metastasis in a Murine Model of Prostate Cancer. Biomed. Pharmacother.101, 938944. 10.1016/j.biopha.2018.03.012

  • 111

    HirookaA.TamiyaA.KanazuM.NonakaJ.YonezawaT.AsamiK.et al (2016). Brain Metastasis of Pleural Mesothelioma after a Subarachnoid Hemorrhage. Intern. Med.55 (7), 779781. 10.2169/internalmedicine.55.3765

  • 112

    HoT. T. B.NastiA.SekiA.KomuraT.InuiH.KozakaT.et al (2020). Combination of Gemcitabine and Anti-PD-1 Antibody Enhances the Anticancer Effect of M1 Macrophages and the Th1 Response in a Murine Model of Pancreatic Cancer Liver Metastasis. J. Immunother. Cancer8 (2), e001367. 10.1136/jitc-2020-001367

  • 113

    HoffmanH. A.LiC. H.EversonR. G.StrunckJ. L.YongW. H.LuD. C. (2017). Primary Lung Metastasis of Glioblastoma Multiforme with Epidural Spinal Metastasis: Case Report. J. Clin. Neurosci.41, 9799. 10.1016/j.jocn.2017.03.033

  • 114

    HongC.-S.SharmaP.YerneniS. S.SimmsP.JacksonE. K.WhitesideT. L.et al (2017). Circulating Exosomes Carrying an Immunosuppressive Cargo Interfere with Cellular Immunotherapy in Acute Myeloid Leukemia. Sci. Rep.7 (1), 14684. 10.1038/s41598-017-14661-w

  • 115

    HongL.QiuH.MeiZ.ZhangH.LiuS.CaoH. (2018). Ovarian Cancer Initially Presenting with Supra-clavicular L-ymph N-ode M-etastasis: A C-ase R-eport. Oncol. Lett.16 (1), 505510. 10.3892/ol.2018.8664

  • 116

    HoodJ. L.SanR. S.WicklineS. A. (2011). Exosomes Released by Melanoma Cells Prepare sentinel Lymph Nodes for Tumor Metastasis. Cancer Res.71 (11), 37923801. 10.1158/0008-5472.CAN-10-4455

  • 117

    HoshinoA.Costa-SilvaB.ShenT.-L.RodriguesG.HashimotoA.Tesic MarkM.et al (2015). Tumour Exosome Integrins Determine Organotropic Metastasis. Nature527 (7578), 329335. 10.1038/nature15756

  • 118

    HosonagaM.SayaH.ArimaY. (2020). Molecular and Cellular Mechanisms Underlying Brain Metastasis of Breast Cancer. Cancer Metastasis Rev.39 (3), 711720. 10.1007/s10555-020-09881-y

  • 119

    HsiehY.-S.ChuS.-C.HuangS.-C.KaoS.-H.LinM.-S.ChenP.-N. (2021). Gossypol Reduces Metastasis and Epithelial-Mesenchymal Transition by Targeting Protease in Human Cervical Cancer. Am. J. Chin. Med.49 (1), 181198. 10.1142/S0192415X21500105

  • 120

    HsuY.-L.HungJ.-Y.ChangW.-A.JianS.-F.LinY.-S.PanY.-C.et al (2018). Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN. Mol. Ther.26 (2), 568581. 10.1016/j.ymthe.2017.11.016

  • 121

    HsuY.-L.HungJ.-Y.ChangW.-A.LinY.-S.PanY.-C.TsaiP.-H.et al (2017). Hypoxic Lung Cancer-Secreted Exosomal miR-23a Increased Angiogenesis and Vascular Permeability by Targeting Prolyl Hydroxylase and Tight junction Protein ZO-1. Oncogene36 (34), 49294942. 10.1038/onc.2017.105

  • 122

    HuC.YangJ.HuangZ.LiuC.LinY.TongY.et al (2020). Diagnostic and Prognostic Nomograms for Bone Metastasis in Hepatocellular Carcinoma. BMC Cancer20 (1), 494. 10.1186/s12885-020-06995-y

  • 123

    HuH.-Y.YuC.-H.ZhangH.-H.ZhangS.-Z.YuW.-Y.YangY.et al (2019). Exosomal miR-1229 Derived from Colorectal Cancer Cells Promotes Angiogenesis by Targeting HIPK2. Int. J. Biol. Macromolecules132, 470477. 10.1016/j.ijbiomac.2019.03.221

  • 124

    HuJ. L.WangW.LanX. L.ZengZ. C.LiangY. S.YanY. R.et al (2019). CAFs Secreted Exosomes Promote Metastasis and Chemotherapy Resistance by Enhancing Cell Stemness and Epithelial-Mesenchymal Transition in Colorectal Cancer. Mol. Cancer18 (1), 91. 10.1186/s12943-019-1019-x

  • 125

    HuY.LiD.WuA.QiuX.DiW.HuangL.et al (2017). TWEAK-stimulated Macrophages Inhibit Metastasis of Epithelial Ovarian Cancer via Exosomal Shuttling of microRNA. Cancer Lett.393, 6067. 10.1016/j.canlet.2017.02.009

  • 126

    HuangC.-S.HoJ.-Y.ChiangJ.-H.YuC.-P.YuD.-S. (2020a). Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells. Cells9 (6), 1419. 10.3390/cells9061419

  • 127

    HuangR.RofstadE. K. (2018). Integrins as Therapeutic Targets in the Organ-specific Metastasis of Human Malignant Melanoma. J. Exp. Clin. Cancer Res.37 (1), 92. 10.1186/s13046-018-0763-x

  • 128

    HuangR.WuJ.ZhengZ.WangG.SongD.YanP.et al (2019). The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Mesothelioma with Bone Metastasis. Front. Bioeng. Biotechnol.7, 257. 10.3389/fbioe.2019.00257

  • 129

    HuangX.-Y.HuangZ.-L.HuangJ.XuB.HuangX.-Y.XuY.-H.et al (2020b). Exosomal circRNA-100338 Promotes Hepatocellular Carcinoma Metastasis via Enhancing Invasiveness and Angiogenesis. J. Exp. Clin. Cancer Res.39 (1), 20. 10.1186/s13046-020-1529-9

  • 130

    HwangJ. H.YooH. J.LimM. C.SeoS.-S.KangS.KimJ.-Y.et al (2013). Brain Metastasis in Patients with Uterine Cervical Cancer. J. Obstet. Gynaecol. Res.39 (1), 287291. 10.1111/j.1447-0756.2012.01927.x

  • 131

    HyunY.-M.SeoS.-U.ChoiW. S.KwonH.-J.KimD.-Y.JeongS.et al (2020). Endogenous DEL-1 Restrains Melanoma Lung Metastasis by Limiting Myeloid Cell-Associated Lung Inflammation. Sci. Adv.6 (45). 10.1126/sciadv.abc4882

  • 132

    IkegamiT.YoshizumiT.KawasakiJ.NagatsuA.UchiyamaH.HaradaN.et al (2017). Surgical Resection for Lymph Node Metastasis after Liver Transplantation for Hepatocellular Carcinoma. Ar37 (2), 891896. 10.21873/anticanres.11395

  • 133

    ImuraY.TateiwaD.SugimotoN.InoueA.WakamatsuT.OutaniH.et al (2020). Prognostic Factors and Skeletal-related E-vents in P-atients with B-one M-etastasis from G-astric C-ancer. Mol. Clin. Oncol.13 (4), 31. 10.3892/mco.2020.2101

  • 134

    JamjoomA. B.JamjoomZ. A. B.RahmanN.-U.Al-RikabiA. C. (1997). Cervical Lymph Node Metastasis from a Glioblastoma Multiforme in a Child: Report of a Case and a Review of the Literature. Ann. Saudi Med.17 (3), 340343. 10.5144/0256-4947.1997.340

  • 135

    JiL.FanL.ZhuX.GaoY.WangZ. (2020). A Prognostic Model for Breast Cancer with Liver Metastasis. Front. Oncol.10, 1342. 10.3389/fonc.2020.01342

  • 136

    JiangK.DongC.YinZ.LiR.MaoJ.WangC.et al (2020). Exosome-derived ENO1 Regulates Integrin α6β4 Expression and Promotes Hepatocellular Carcinoma Growth and Metastasis. Cel Death Dis11 (11), 972. 10.1038/s41419-020-03179-1

  • 137

    JieG. N.SingW. C.ChingC. Y.Tiffanyfnm. (2011). Is Lymph Node Metastasis a Common Feature of Gastrointestinal Stromal Tumor?Clin. Nucl. Med.36 (8), 678682. 10.1097/RLU.0b013e318219ad31

  • 138

    KalluriR. (2016). The Biology and Function of Exosomes in Cancer. J. Clin. Invest.126 (4), 12081215. 10.1172/JCI81135

  • 139

    KanayamaT.MabuchiS.ShimuraK.HisamatsuT.IsohashiF.HamasakiT.et al (2015). Prognostic Factors for Survival in Cervical Cancer Patients with Bone Metastasis. Eur. J. Gynaecol. Oncol.36 (3), 290293.

  • 140

    KandaM.FujiiT.NagaiS.KoderaY.KanzakiA.SahinT. T.et al (2011). Pattern of Lymph Node Metastasis Spread in Pancreatic Cancer. Pancreas40 (6), 951955. 10.1097/MPA.0b013e3182148342

  • 141

    KapoorH.SanampudiS.OwenJ.RaissiD. (2020). Lung Metastasis Postradioembolization of Hepatocellular Carcinoma with Tumor in Vein. ACG Case Rep. J.7 (2), e00322. 10.14309/crj.0000000000000322

  • 142

    KatonaF.MurnyákB.Marko-VargaG.HortobágyiT. (2017). A Melanoma És Az Agyi Áttétképződés Molekuláris Háttere. Orvosi Hetilap158 (28), 10831091. 10.1556/650.2017.30793

  • 143

    KawaiA.NagasakaY.MurakiM.FukuokaM.SatouT.KimuraM.et al (1997). Brain Metastasis in Malignant Pleural Mesothelioma. Intern. Med.36 (8), 591594. 10.2169/internalmedicine.36.591

  • 144

    KhanS.AspeJ. R.AsumenM. G.AlmaguelF.OdumosuO.Acevedo-MartinezS.et al (2009). Extracellular, Cell-Permeable Survivin Inhibits Apoptosis while Promoting Proliferative and Metastatic Potential. Br. J. Cancer100 (7), 10731086. 10.1038/sj.bjc.6604978

  • 145

    KhanS.JutzyJ. M. S.AspeJ. R.McGregorD. W.NeidighJ. W.WallN. R. (2011). Survivin Is Released from Cancer Cells via Exosomes. Apoptosis16 (1), 112. 10.1007/s10495-010-0534-4

  • 146

    KimE.-K.SongM.-J.JungY.LeeW.-S.JangH. H. (2019a). Proteomic Analysis of Primary Colon Cancer and Synchronous Solitary Liver Metastasis. Cancer Genomics Proteomics16 (6), 583592. 10.21873/cgp.20161

  • 147

    KimH.LeeK. K.HeoM. H.KimJ. Y. (2019b). The Prognostic Factors Influencing Overall Survival in Uterine Cervical Cancer with Brain Metastasis. Korean J. Intern. Med.34 (6), 13241332. 10.3904/kjim.2018.051

  • 148

    KimJ.PiaoH.-L.KimB.-J.YaoF.HanZ.WangY.et al (2018). Long Noncoding RNA MALAT1 Suppresses Breast Cancer Metastasis. Nat. Genet.50 (12), 17051715. 10.1038/s41588-018-0252-3

  • 149

    KimJ. W.WieckowskiE.TaylorD. D.ReichertT. E.WatkinsS.WhitesideT. L. (2005). Fas Ligand-Positive Membranous Vesicles Isolated from Sera of Patients with Oral Cancer Induce Apoptosis of Activated T Lymphocytes. Clin. Cancer Res.11 (3), 10101020. 10.1158/1078-0432.ccr-05-1346

  • 150

    KimR.SongJ.KimS. B. (2020). Concurrent Hepatocellular Carcinoma Metastasis to Stomach, colon, and Brain: A Case Report. Wjcc8 (16), 35343541. 10.12998/wjcc.v8.i16.3534

  • 151

    KimS.BaeW. J.AhnJ. M.HeoJ.-H.KimK.-M.ChoiK. W.et al (2021). MicroRNA Signatures Associated with Lymph Node Metastasis in Intramucosal Gastric Cancer. Mod. Pathol.34 (3), 672683. 10.1038/s41379-020-00681-x

  • 152

    KimW.Seok KangY.Soo KimJ.ShinN.-Y.HanksS. K.SongW. K. (2008). The Integrin-Coupled Signaling Adaptor p130Cas Suppresses Smad3 Function in Transforming Growth Factor-β Signaling. MBoC19 (5), 21352146. 10.1091/mbc.E07-10-0991

  • 153

    KircherD.SilvisM.ChoJ.HolmenS. (2016). Melanoma Brain Metastasis: Mechanisms, Models, and Medicine. Ijms17 (9), 1468. 10.3390/ijms17091468

  • 154

    KlemkeM.WeschenfelderT.KonstandinM. H.SamstagY. (2007). High Affinity Interaction of Integrin α4β1 (VLA-4) and Vascular Cell Adhesion Molecule 1 (VCAM-1) Enhances Migration of Human Melanoma Cells across Activated Endothelial Cell Layers. J. Cel. Physiol.212 (2), 368374. 10.1002/jcp.21029

  • 155

    KleppeM.WangT.Van GorpT.SlangenB. F. M.KruseA. J.KruitwagenR. F. P. M. (2011). Lymph Node Metastasis in Stages I and II Ovarian Cancer: a Review. Gynecol. Oncol.123 (3), 610614. 10.1016/j.ygyno.2011.09.013

  • 156

    KlingenbergS.JochumsenM. R.UlhøiB. P.FredsøeJ.SørensenK. D.BorreM.et al (2021). 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer. J. Nucl. Med.62 (2), 214220. 10.2967/jnumed.120.245605

  • 157

    KoflerB.KerschbaumerJ.SchartingerV. H.PoschA.GizewskiE. R.WidmannG. (2017). Hirnmetastase versus Strahlennekrose nach Kopf-Hals-Karzinom. Radiologe57 (5), 392396. 10.1007/s00117-017-0219-x

  • 158

    KogureT.LinW.-L.YanI. K.BraconiC.PatelT. (2011). Intercellular Nanovesicle-Mediated microRNA Transfer: a Mechanism of Environmental Modulation of Hepatocellular Cancer Cell Growth. Hepatology54 (4), 12371248. 10.1002/hep.24504

  • 159

    KongJ.TianH.ZhangF.ZhangZ.LiJ.LiuX.et al (2019). Extracellular Vesicles of Carcinoma-Associated Fibroblasts Creates a Pre-metastatic Niche in the Lung through Activating Fibroblasts. Mol. Cancer18 (1), 175. 10.1186/s12943-019-1101-4

  • 160

    KongM.JinJ.CaiX.ShenJ.MaD.YeM.et al (2017). Characteristics of Lymph Node Metastasis in Resected Adenosquamous Lung Cancer. Medicine (Baltimore)96 (48), e8870. 10.1097/MD.0000000000008870

  • 161

    KongX.ZhangJ.LiJ.ShaoJ.FangL. (2018). MiR-130a-3p Inhibits Migration and Invasion by Regulating RAB5B in Human Breast Cancer Stem Cell-like Cells. Biochem. Biophysical Res. Commun.501 (2), 486493. 10.1016/j.bbrc.2018.05.018

  • 162

    KoppH.-G.PlackeT.SalihH. R. (2009). Platelet-Derived Transforming Growth Factor-β Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity. Cancer Res.69 (19), 77757783. 10.1158/0008-5472.CAN-09-2123

  • 163

    KosakaN.IguchiH.HagiwaraK.YoshiokaY.TakeshitaF.OchiyaT. (2013). Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic microRNAs Regulate Cancer Cell Metastasis. J. Biol. Chem.288 (15), 1084910859. 10.1074/jbc.M112.446831

  • 164

    KuboN.TakeuchiN. (2017). Gastrointestinal Stromal Tumor of the Stomach with Axillary Lymph Node Metastasis: A Case Report. Wjg23 (9), 17201724. 10.3748/wjg.v23.i9.1720

  • 165

    KucharzewskaP.ChristiansonH. C.WelchJ. E.SvenssonK. J.FredlundE.RingnerM.et al (2013). Exosomes Reflect the Hypoxic Status of Glioma Cells and Mediate Hypoxia-dependent Activation of Vascular Cells during Tumor Development. Proc. Natl. Acad. Sci.110 (18), 73127317. 10.1073/pnas.1220998110

  • 166

    KumarL.BhargavaV. L.RaoR. C. K.RathG. K.KatariaS. P. (1992). Bone Metastasis in Ovarian Cancer. Asia Oceania J. Obstet. Gynaecol.18 (4), 309313. 10.1111/j.1447-0756.1992.tb00324.x

  • 167

    KuoS.-W.KeF.-C.ChangG.-D.LeeM.-T.HwangJ.-J. (2011). Potential Role of Follicle-Stimulating Hormone (FSH) and Transforming Growth Factor (TGFβ1) in the Regulation of Ovarian Angiogenesis. J. Cel. Physiol.226 (6), 16081619. 10.1002/jcp.22491

  • 168

    KuznetsovH. S.MarshT.MarkensB. A.CastañoZ.Greene-ColozziA.HayS. A.et al (2012). Identification of Luminal Breast Cancers that Establish a Tumor-Supportive Macroenvironment Defined by Proangiogenic Platelets and Bone Marrow-Derived Cells. Cancer Discov.2 (12), 11501165. 10.1158/2159-8290.CD-12-0216

  • 169

    LalP.TiwariA.KumarN.BajpaiR. (2007). Bone Metastasis from Ovarian Cancer. J. Can. Res. Ther.3 (1), 3436. 10.4103/0973-1482.31969

  • 170

    LambertA. W.PattabiramanD. R.WeinbergR. A. (2017). Emerging Biological Principles of Metastasis. Cell168 (4), 670691. 10.1016/j.cell.2016.11.037

  • 171

    LanJ.SunL.XuF.LiuL.HuF.SongD.et al (2019). M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer. Cancer Res.79 (1), 146158. 10.1158/0008-5472.CAN-18-0014

  • 172

    LangH.-L.HuG.-W.ZhangB.KuangW.ChenY.WuL.et al (2017b). Glioma Cells Enhance Angiogenesis and Inhibit Endothelial Cell Apoptosis through the Release of Exosomes that Contain Long Non-coding RNA CCAT2. Oncol. Rep.38 (2), 785798. 10.3892/or.2017.5742

  • 173

    LangH. L.HuG. W.ChenY.LiuY.TuW.LuY. M.et al (2017a). Glioma Cells Promote Angiogenesis through the Release of Exosomes Containing Long Non-coding RNA POU3F3. Eur. Rev. Med. Pharmacol. Sci.21 (5), 959972.

  • 174

    LauriniR. N. (1974). Diffuse Pleural Mesothelioma with Distant Bone Metastasis. Acta Pathol. Microbiol. Scand. A.82A (2), 296298. 10.1111/j.1699-0463.1974.tb03854.x

  • 175

    Lázaro‐IbáñezE.Sanz‐GarciaA.VisakorpiT.Escobedo‐LuceaC.SiljanderP.Ayuso‐SacidoÁ.et al (2014). Different gDNA Content in the Subpopulations of Prostate Cancer Extracellular Vesicles: Apoptotic Bodies, Microvesicles, and Exosomes. Prostate74 (14), 13791390. 10.1002/pros.22853

  • 176

    LeeJ.-K.ParkS.-R.JungB.-K.JeonY.-K.LeeY.-S.KimM.-K.et al (2013b). Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells. PLoS One8 (12), e84256. 10.1371/journal.pone.0084256

  • 177

    LeeJ.KimK. E.ChoiD.-K.JangJ. Y.JungJ.-J.KiyonariH.et al (2013a). Angiopoietin-1 Guides Directional Angiogenesis through Integrin α V β 5 Signaling for Recovery of Ischemic Retinopathy. Sci. Transl. Med.5 (203), 203ra127. 10.1126/scitranslmed.3006666

  • 178

    LeightJ. L.WozniakM. A.ChenS.LynchM. L.ChenC. S. (2012). Matrix Rigidity Regulates a Switch between TGF-Β1-Induced Apoptosis and Epithelial-Mesenchymal Transition. MBoC23 (5), 781791. 10.1091/mbc.E11-06-0537

  • 179

    LeitingerB. (2011). Transmembrane Collagen Receptors. Annu. Rev. Cel Dev. Biol.27, 265290. 10.1146/annurev-cellbio-092910-154013

  • 180

    LemkeJ.ScheeleJ.KapapaT.WirtzC.Henne-BrunsD.KornmannM. (2013). Brain Metastasis in Pancreatic Cancer. Ijms14 (2), 41634173. 10.3390/ijms14024163

  • 181

    LeventalK. R.YuH.KassL.LakinsJ. N.EgebladM.ErlerJ. T.et al (2009). Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling. Cell139 (5), 891906. 10.1016/j.cell.2009.10.027

  • 182

    LiB.MaoR.LiuC.ZhangW.TangY.GuoZ. (2018). LncRNA FAL1 Promotes Cell Proliferation and Migration by Acting as a CeRNA of miR-1236 in Hepatocellular Carcinoma Cells. Life Sci.197, 122129. 10.1016/j.lfs.2018.02.006

  • 183

    LiF.DaiY.XuH.HuangK.ZhouY.LuoD.et al (2019). XPNPEP2 Is Associated with Lymph Node Metastasis in Prostate Cancer Patients. Sci. Rep.9 (1), 10078. 10.1038/s41598-019-45245-5

  • 184

    LiJ.LiZ.JiangP.PengM.ZhangX.ChenK.et al (2018). Circular RNA IARS (Circ-IARS) Secreted by Pancreatic Cancer Cells and Located within Exosomes Regulates Endothelial Monolayer Permeability to Promote Tumor Metastasis. J. Exp. Clin. Cancer Res.37 (1), 177. 10.1186/s13046-018-0822-3

  • 185

    LiK.ChenY.LiA.TanC.LiuX. (2019). Exosomes Play Roles in Sequential Processes of Tumor Metastasis. Int. J. Cancer144 (7), 14861495. 10.1002/ijc.31774

  • 186

    LiR.WangY.ZhangX.FengM.MaJ.LiJ.et al (2019). Exosome-mediated Secretion of LOXL4 Promotes Hepatocellular Carcinoma Cell Invasion and Metastasis. Mol. Cancer18 (1), 18. 10.1186/s12943-019-0948-8

  • 187

    LiY.LiQ.LiD.GuJ.QianD.QinX.et al (2021). Exosome Carrying PSGR Promotes Stemness and Epithelial-Mesenchymal Transition of Low Aggressive Prostate Cancer Cells. Life Sci.264, 118638. 10.1016/j.lfs.2020.118638

  • 188

    LiY.LiangY.SangY.SongX.ZhangH.LiuY.et al (2018). MiR-770 Suppresses the Chemo-Resistance and Metastasis of Triple Negative Breast Cancer via Direct Targeting of STMN1. Cel Death Dis9 (1), 14. 10.1038/s41419-017-0030-7

  • 189

    LiY.XiY.ZhuG.JiaJ.HuangH.LiuY.et al (2019). Downregulated IGFBP7 Facilitates Liver Metastasis by Modulating Epithelial-mesenchymal T-ransition in colon C-ancer. Oncol. Rep.42 (5), 19351945. 10.3892/or.2019.7303

  • 190

    LiZ.JiangP.LiJ.PengM.ZhaoX.ZhangX.et al (2018). Tumor-derived Exosomal Lnc-Sox2ot Promotes EMT and Stemness by Acting as a ceRNA in Pancreatic Ductal Adenocarcinoma. Oncogene37 (28), 38223838. 10.1038/s41388-018-0237-9

  • 191

    LinW.-H.ChangY.-W.HongM.-X.HsuT.-C.LeeK.-C.LinC.et al (2021). STAT3 Phosphorylation at Ser727 and Tyr705 Differentially Regulates the EMT-MET Switch and Cancer Metastasis. Oncogene40 (4), 791805. 10.1038/s41388-020-01566-8

  • 192

    LinY.HuangS.-T.JiangY.-M.PanX.-B. (2017). Hemorrhage of Brain Metastasis Is a Poor Prognostic Factor in Hepatocellular Carcinoma Patients. Oncotarget8 (54), 9324593250. 10.18632/oncotarget.21449

  • 193

    LiuD.KangH.GaoM.JinL.ZhangF.ChenD.et al (2020). Exosome‐transmitted circ_MMP2 Promotes Hepatocellular Carcinoma Metastasis by Upregulating MMP2. Mol. Oncol.14 (6), 13651380. 10.1002/1878-0261.12637

  • 194

    LiuH.YeX.LiD.YaoQ.LiY. (2021). Incidence, Clinical Risk and Prognostic Factors for Liver Metastasis in Patients with Cervical Cancer: a Population-Based Retrospective Study. BMC Cancer21 (1), 421. 10.1186/s12885-021-08127-6

  • 195

    LiuJ.AgarwalS. (2010). Mechanical Signals Activate Vascular Endothelial Growth Factor Receptor-2 to Upregulate Endothelial Cell Proliferation during Inflammation. J.I.185 (2), 12151221. 10.4049/jimmunol.0903660

  • 196

    LiuT.ZhangX.DuL.WangY.LiuX.TianH.et al (2019). Exosome-transmitted miR-128-3p Increase Chemosensitivity of Oxaliplatin-Resistant Colorectal Cancer. Mol. Cancer18 (1), 43. 10.1186/s12943-019-0981-7

  • 197

    LiuY.CaoX. (2016). Characteristics and Significance of the Pre-metastatic Niche. Cancer Cell30 (5), 668681. 10.1016/j.ccell.2016.09.011

  • 198

    LiuY.GuY.HanY.ZhangQ.JiangZ.ZhangX.et al (2016a). Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils. Cancer Cell30 (2), 243256. 10.1016/j.ccell.2016.06.021

  • 199

    LiuY.LuoF.WangB.LiH.XuY.LiuX.et al (2016b). STAT3-regulated Exosomal miR-21 Promotes Angiogenesis and Is Involved in Neoplastic Processes of Transformed Human Bronchial Epithelial Cells. Cancer Lett.370 (1), 125135. 10.1016/j.canlet.2015.10.011

  • 200

    LiuY.RenW.BaiY.WanL.SunX.LiuY.et al (2018a). Oxyresveratrol Prevents Murine H22 Hepatocellular Carcinoma Growth and Lymph Node Metastasis via Inhibiting Tumor Angiogenesis and Lymphangiogenesis. J. Nat. Med.72 (2), 481492. 10.1007/s11418-018-1173-2

  • 201

    LiuY.WuT.LuD.ZhenJ.ZhangL. (2018b). CD44 Overexpression Related to Lymph Node Metastasis and Poor Prognosis of Pancreatic Cancer. Int. J. Biol. Markers33 (3), 308313. 10.1177/1724600817746951

  • 202

    LiuZ.-L.WangC.ChenH.-J.LiX.DaiL.-J.DingZ.-Y. (2017). Bone Metastasis from Lung Cancer Identified by Genetic Profiling. Oncol. Lett.13 (2), 847850. 10.3892/ol.2016.5458

  • 203

    Lo CiceroA.MajkowskaI.NagaseH.Di LiegroI.TroebergL. (2012). Microvesicles Shed by Oligodendroglioma Cells and Rheumatoid Synovial Fibroblasts Contain Aggrecanase Activity. Matrix Biol.31 (4), 229233. 10.1016/j.matbio.2012.02.005

  • 204

    LongoR.BastienC.CampitielloM.PlastinoF.RozziA. (2020). Breast and Axillary Lymph Node Metastasis from Ovarian Cancer: A Case Report. Am. J. Case Rep.21, e925089. 10.12659/AJCR.925089

  • 205

    LuY.-J.YangY.YuanY.-H.WangW.-J.CuiM.-T.TangH.-Y.et al (2020). A Novel Nomogram Based on SEER Database for the Prediction of Liver Metastasis in Patients with Small-Cell Lung Cancer. Ann. Palliat. Med.9 (5), 31233137. 10.21037/apm-20-886

  • 206

    LuanW.DingY.XiH.RuanH.LuF.MaS.et al (2021). Exosomal miR-106b-5p Derived from Melanoma Cell Promotes Primary Melanocytes Epithelial-Mesenchymal Transition through Targeting EphA4. J. Exp. Clin. Cancer Res.40 (1), 107. 10.1186/s13046-021-01906-w

  • 207

    LudwigN.WhitesideT. L. (2018). Potential Roles of Tumor-Derived Exosomes in Angiogenesis. Expert Opin. Ther. Targets22 (5), 409417. 10.1080/14728222.2018.1464141

  • 208

    LudwigS.FlorosT.TheodorakiM.-N.HongC.-S.JacksonE. K.LangS.et al (2017). Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer. Clin. Cancer Res.23 (16), 48434854. 10.1158/1078-0432.CCR-16-2819

  • 209

    LugaV.ZhangL.Viloria-PetitA. M.OgunjimiA. A.InanlouM. R.ChiuE.et al (2012). Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration. Cell151 (7), 15421556. 10.1016/j.cell.2012.11.024

  • 210

    LuoK.-J.ChenC.-X.YangJ.-P.HuangY.-C.CardenasE. R.JiangJ. X. (2020a). Connexins in Lung Cancer and Brain Metastasis. Front. Oncol.10, 599383. 10.3389/fonc.2020.599383

  • 211

    LuoY.MaJ.LiuF.GuoJ.GuiR. (2020b). Diagnostic Value of Exosomal circMYC in Radioresistant Nasopharyngeal Carcinoma. Head & Neck42 (12), 37023711. 10.1002/hed.26441

  • 212

    LuoZ.RongZ.HuangC. (2019). Surgery Strategies for Gastric Cancer with Liver Metastasis. Front. Oncol.9, 1353. 10.3389/fonc.2019.01353

  • 213

    MaB.WellsA.WeiL.ZhengJ. (2021). Prostate Cancer Liver Metastasis: Dormancy and Resistance to Therapy. Semin. Cancer Biol.71, 29. 10.1016/j.semcancer.2020.07.004

  • 214

    MaJ.ZhangJ.WengY. C.WangJ. C. (2018). EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer. Mol. Cell41 (9), 868880. 10.14348/molcells.2018.0109

  • 215

    MaR.YeX.ChengH.CuiH.ChangX. (2021). Tumor-derived Exosomal circRNA051239 Promotes Proliferation and Migration of Epithelial Ovarian Cancer. Am. J. Transl Res.13 (3), 11251139.

  • 216

    MaR.-Y.ZhangH.LiX.-F.ZhangC.-B.SelliC.TagliaviniG.et al (2020a). Monocyte-derived Macrophages Promote Breast Cancer Bone Metastasis Outgrowth. J. Exp. Med.217 (11). 10.1084/jem.20191820

  • 217

    MaR.FengY.LinS.ChenJ.LinH.LiangX.et al (2015). Mechanisms Involved in Breast Cancer Liver Metastasis. J. Transl Med.13, 64. 10.1186/s12967-015-0425-0

  • 218

    MaZ.-j.WangY.LiH.-f.LiuM.-H.BiF.-r.MaL.et al (2020b). LncZEB1-AS1 Regulates Hepatocellular Carcinoma Bone Metastasis via Regulation of the miR-302b-EGFR-Pi3k-AKT axis. J. Cancer11 (17), 51185128. 10.7150/jca.45995

  • 219

    MahabeleshwarG. H.ChenJ.FengW.SomanathP. R.RazorenovaO. V.ByzovaT. V. (2008). Integrin Affinity Modulation in Angiogenesis. Cell Cycle7 (3), 335347. 10.4161/cc.7.3.5234

  • 220

    MahabeleshwarG. H.FengW.ReddyK.PlowE. F.ByzovaT. V. (2007). Mechanisms of Integrin-Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis. Circ. Res.101 (6), 570580. 10.1161/CIRCRESAHA.107.155655

  • 221

    MakinoH.NishioS.TsubamotoH.ShimadaM.NishikawaR.KaiK.et al (2016). Treatment and Prognosis of Bone Metastasis from Cervical Cancer (KCOG-G1202s). J. Obstet. Gynaecol. Res.42 (6), 701706. 10.1111/jog.12956

  • 222

    MallaR. R.PandrangiS.KumariS.GavaraM. M.BadanaA. K. (2018). Exosomal Tetraspanins as Regulators of Cancer Progression and Metastasis and Novel Diagnostic Markers. Asia-pac J. Clin. Oncol.14 (6), 383391. 10.1111/ajco.12869

  • 223

    MannavolaF.MandalaM.TodiscoA.SileniV. C.PallaM.MinisiniA. M.et al (2020). An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival. Front. Oncol.10, 1652. 10.3389/fonc.2020.01652

  • 224

    Marchand CretyC.EttalhaouiL.Servagi VernatS. (2020). Cystic Brain Metastasis from Prostate Cancer: A Case Report and Literature Review. Urol. Case Rep.32, 101219. 10.1016/j.eucr.2020.101219

  • 225

    MarzulloA.SerioG.PezzutoF.FortarezzaF.CazzatoG.CaporussoC.et al (2020). A Single Liver Metastasis from Pleural Biphasic Mesothelioma. Diagnostics10 (8), 555. 10.3390/diagnostics10080555

  • 226

    MatsumotoH.YoshidaY. (2015). Brain Metastasis from Pancreatic Cancer: A Case Report and Literature Review. Asian J. Neurosurg.10 (1), 3539. 10.4103/1793-5482.151507

  • 227

    MatsumuraT.OhzatoH.YamamotoT.OtaK.MabuchiE.MiwaH.et al (2009). A Case of Postoperative Brain Metastasis Originated from Pancreatic Cancer Which Was Successfully Treated by Resection and Postoperative Irradiation. Gan To Kagaku Ryoho36 (12), 24332435.

  • 228

    MauriC.BosmaA. (2012). Immune Regulatory Function of B Cells. Annu. Rev. Immunol.30, 221241. 10.1146/annurev-immunol-020711-074934

  • 229

    McCarthyD. H. (2001). Letters to the Editor. Prog. Transpl.11 (3), 162. 10.7182/prtr.11.3.hh6665126211678310.1177/152692480101100302

  • 230

    MerkowJ.PanicciaA.JonesE.JonesT.HodgesM.StovallR.et al (2016). Association of sentinel Lymph Node Diameter with Melanoma Metastasis. Am. J. Surg.212 (2), 315320. 10.1016/j.amjsurg.2015.09.022

  • 231

    MermodM.BongiovanniM.PetrovaT.GounE.SimonC.TolstonogG.et al (2019). Prediction of Occult Lymph Node Metastasis in Head and Neck Cancer with CD31 Vessel Quantification. Otolaryngol. Head Neck Surg.160 (2), 277283. 10.1177/0194599818791779

  • 232

    MikamiJ.KimuraY.MakariY.FujitaJ.KishimotoT.SawadaG.et al (2017). Clinical Outcomes and Prognostic Factors for Gastric Cancer Patients with Bone Metastasis. World J. Surg. Onc15 (1), 8. 10.1186/s12957-016-1091-2

  • 233

    MinciacchiV. R.FreemanM. R.Di VizioD. (2015). Extracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large Oncosomes. Semin. Cel Dev. Biol.40, 4151. 10.1016/j.semcdb.2015.02.010

  • 234

    MoyA. P.MochelM. C.MuzikanskyA.DuncanL. M.KraftS. (2017). Lymphatic Invasion Predicts sentinel Lymph Node Metastasis and Adverse Outcome in Primary Cutaneous Melanoma. J. Cutan. Pathol.44 (9), 734739. 10.1111/cup.12969

  • 235

    Muhsin-SharafaldineM.-R.SaundersonS. C.DunnA. C.McLellanA. D. (2017). Melanoma Growth and Lymph Node Metastasis Is Independent of Host CD169 Expression. Biochem. Biophysical Res. Commun.486 (4), 965970. 10.1016/j.bbrc.2017.03.138

  • 236

    NabetB. Y.QiuY.ShabasonJ. E.WuT. J.YoonT.KimB. C.et al (2017). Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer. Cell170 (2), 352 e313366. 10.1016/j.cell.2017.06.031

  • 237

    NagataA.KanemasaY.KikuchiM.OtaniR.YamadaR.MotoiT.et al (2020). Bone Marrow Metastasis of Glioblastoma Multiforme Mimicking Acute Myeloid Leukemia. Oxf Med. Case Rep.2020 (6), omaa040. 10.1093/omcr/omaa040

  • 238

    NagyJ. A.DvorakH. F. (2012). Heterogeneity of the Tumor Vasculature: the Need for New Tumor Blood Vessel Type-specific Targets. Clin. Exp. Metastasis29 (7), 657662. 10.1007/s10585-012-9500-6

  • 239

    NakamaraN.MatsuiT.IshibashiY.SotokawauchiA.FukamiK.HigashimotoY.et al (2017b). RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice. Mol. Med.23, 295306. 10.2119/molmed.2017.00099

  • 240

    NakamuraK.SawadaK.KinoseY.YoshimuraA.TodaA.NakatsukaE.et al (2017a). Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells. Mol. Cancer Res.15 (1), 7892. 10.1158/1541-7786.MCR-16-0191

  • 241

    NamH. C.SungP. S.SongD. S.KwonJ. H.NamS. W.YoonD. J.et al (2019). Control of Intracranial Disease Is Associated with Improved Survival in Patients with Brain Metastasis from Hepatocellular Carcinoma. Int. J. Clin. Oncol.24 (6), 666676. 10.1007/s10147-019-01407-z

  • 242

    NamburiS.BroxmeyerH. E.HongC.-S.WhitesideT. L.BoyiadzisM. (2021). DPP4+ Exosomes in AML Patients' Plasma Suppress Proliferation of Hematopoietic Progenitor Cells. Leukemia35 (7), 19251932. 10.1038/s41375-020-01047-7

  • 243

    NanceM. E.BiedermannG. B.BhatA. P.DavisR. M. (2020). Chemorefractory Liver Metastasis from Cervical Cancer Successfully Treated with a Combination of Yttrium-90 and Immunotherapy. Radiol. Case Rep.15 (8), 13591365. 10.1016/j.radcr.2020.06.010

  • 244

    NaoeH.KakuE.IdoY.GushimaR.MakiY.SaitoH.et al (2011). Brain Metastasis from Gastrointestinal Stromal Tumor: a Case Report and Review of the Literature. Case Rep. Gastroenterol.5 (3), 583589. 10.1159/000333403

  • 245

    NartthanarungA.ThanapprapasrK.UdomsubpayakulU.ThanapprapasrD. (2014). Age and Survival of Cervical Cancer Patients with Bone Metastasis. Asian Pac. J. Cancer Prev.15 (19), 84018404. 10.7314/apjcp.2014.15.19.8401

  • 246

    NguyenD. X.BosP. D.MassaguéJ. (2009). Metastasis: from Dissemination to Organ-specific Colonization. Nat. Rev. Cancer9 (4), 274284. 10.1038/nrc2622

  • 247

    NienstedtJ. C.SchroederC.ClauditzT.SimonR.SauterG.MuenscherA.et al (2018). EZH2 Overexpression in Head and Neck Cancer Is Related to Lymph Node Metastasis. J. Oral Pathol. Med.47 (3), 240245. 10.1111/jop.12673

  • 248

    NieswandtB.HafnerM.EchtenacherB.MännelD. N. (1999). Lysis of Tumor Cells by Natural Killer Cells in Mice Is Impeded by Platelets. Cancer Res.59 (6), 12951300.

  • 249

    NishinoH.AbeK.IgarashiM.MiyataM.KitamuraK. (1996). Chemotherapy with Low-Dose Consecutive Cisplatin (Cddp) for Patients with Recurrent and Distant Metastasis of Head and Neck Cancer. Nippon Jibiinkoka Gakkai Kaiho99 (9), 12181222. 10.3950/jibiinkoka.99.1218

  • 250

    NishioN.van den BergN. S.MartinB. A.van KeulenS.FakurnejadS.RosenthalE. L.et al (2021). Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer Using an Anti-EGFR Antibody-Dye Conjugate. J. Nucl. Med.62 (5), 648655. 10.2967/jnumed.120.245241

  • 251

    OharaH.IshibashiY.YoshimuraS.YamazakiR.HataoF.KoshiishiT.et al (2020). Intratumoral Pseudoaneurysm within a Liver Metastasis of Gastric Cancer: a Case Report. Surg. Case Rep.6 (1), 39. 10.1186/s40792-020-00806-z

  • 252

    OkabeH.AokiK.YogosawaS.SaitoM.MarumoK.YoshidaK. (2018). Downregulation of CD24 Suppresses Bone Metastasis of Lung Cancer. Cancer Sci.109 (1), 112120. 10.1111/cas.13435

  • 253

    OutaniH.AkitaH.NakaiT.TakadaR.ImuraY.TanakaT.et al (2018). Clinical Features and Prognosis of Patients with the Bone Metastasis of Pancreatic Cancer. Pancreas47 (7), e43e46. 10.1097/MPA.0000000000001098

  • 254

    PaceK. R.DuttR.GalileoD. S. (2019). Exosomal L1CAM Stimulates Glioblastoma Cell Motility, Proliferation, and Invasiveness. Ijms20 (16), 3982. 10.3390/ijms20163982

  • 255

    PahlJ.CerwenkaA. (2017). Tricking the Balance: NK Cells in Anti-cancer Immunity. Immunobiology222 (1), 1120. 10.1016/j.imbio.2015.07.012

  • 256

    PakneshanS.SafarpourD.TavassoliF.JabbariB. (2014). Brain Metastasis from Ovarian Cancer: a Systematic Review. J. Neurooncol.119 (1), 16. 10.1007/s11060-014-1447-9

  • 257

    PaolettiC.HayesD. F. (2016). Circulating Tumor Cells. Adv. Exp. Med. Biol.882, 235258. 10.1007/978-3-319-22909-6_10

  • 258

    PaolilloM.SchinelliS. (2017). Integrins and Exosomes, a Dangerous Liaison in Cancer Progression. Cancers9 (8), 95. 10.3390/cancers9080095

  • 259

    ParkJ.-M.HanY.-M.JeongM.ChungM. H.KwonC. I.KoK. H.et al (2017). Synthetic 8-hydroxydeoxyguanosine Inhibited Metastasis of Pancreatic Cancer through Concerted Inhibitions of ERM and Rho-GTPase. Free Radic. Biol. Med.110, 151161. 10.1016/j.freeradbiomed.2017.06.003

  • 260

    ParkS.ByunH. K.SeongJ. (2019). Irradiation-Related Lymphopenia for Bone Metastasis from Hepatocellular Carcinoma. Liver Cancer8 (6), 468479. 10.1159/000500461

  • 261

    ParkS. M.Do-ThiV. A.LeeJ. O.LeeH.KimY. S. (2020). Interleukin-9 Inhibits Lung Metastasis of Melanoma through Stimulating Anti-tumor M1 Macrophages. Mol. Cell43 (5), 479490. 10.14348/molcells.2020.0047

  • 262

    PedrosaR. M. S. M.MustafaD. A.SoffiettiR.KrosJ. M. (2018). Breast Cancer Brain Metastasis: Molecular Mechanisms and Directions for Treatment. Neuro Oncol.20 (11), 14391449. 10.1093/neuonc/noy044

  • 263

    PeinadoH.AlečkovićM.LavotshkinS.MateiI.Costa-SilvaB.Moreno-BuenoG.et al (2012). Melanoma Exosomes Educate Bone Marrow Progenitor Cells toward a Pro-metastatic Phenotype through MET. Nat. Med.18 (6), 883891. 10.1038/nm.2753

  • 264

    PeinadoH.LavotshkinS.LydenD. (2011). The Secreted Factors Responsible for Pre-metastatic Niche Formation: Old Sayings and New Thoughts. Semin. Cancer Biol.21 (2), 139146. 10.1016/j.semcancer.2011.01.002

  • 265

    PeinadoH.ZhangH.MateiI. R.Costa-SilvaB.HoshinoA.RodriguesG.et al (2017). Pre-metastatic Niches: Organ-specific Homes for Metastases. Nat. Rev. Cancer17 (5), 302317. 10.1038/nrc.2017.6

  • 266

    PengZ.XuS.LiH.SunC.FuM.GaoM. (2014). Advanced Gastric Cancer with Brain Metastasis Effectively Treated by Arterial Infusion Chemotherapy: A Case Report. Oncol. Lett.7 (2), 449451. 10.3892/ol.2013.1699

  • 267

    PolistinaG. E.MatareseA.CarielloP.CaroppoD.ZamparelliA. S. (2020). Cavitary Lung Metastasis as Relapse of Prostate Cancer. Respir. Med. Case Rep.29, 100973. 10.1016/j.rmcr.2019.100973

  • 268

    ProvenzanoP. P.InmanD. R.EliceiriK. W.KnittelJ. G.YanL.RuedenC. T.et al (2008). Collagen Density Promotes Mammary Tumor Initiation and Progression. BMC Med.6, 11. 10.1186/1741-7015-6-11

  • 269

    PylayevaY.GillenK. M.GeraldW.BeggsH. E.ReichardtL. F.GiancottiF. G. (2009). Ras- and PI3K-dependent Breast Tumorigenesis in Mice and Humans Requires Focal Adhesion Kinase Signaling. J. Clin. Invest.119 (2), 252266. 10.1172/JCI37160

  • 270

    QianB.-Z.PollardJ. W. (2010). Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell141 (1), 3951. 10.1016/j.cell.2010.03.014

  • 271

    QiuJ.-J.LinX.-J.TangX.-Y.ZhengT.-T.LinY.-Y.HuaK.-Q. (2018a). Exosomal Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer. Int. J. Biol. Sci.14 (14), 19601973. 10.7150/ijbs.28048

  • 272

    QiuM.-Z.ShiS.-M.ChenZ.-H.YuH.-E.ShengH.JinY.et al (2018b). Frequency and Clinicopathological Features of Metastasis to Liver, Lung, Bone, and Brain from Gastric Cancer: A SEER-Based Study. Cancer Med.7 (8), 36623672. 10.1002/cam4.1661

  • 273

    QiuX.JiangY.ZhaoQ.YanC.HuangM.JiangT. a. (2020). Could Ultrasound‐Based Radiomics Noninvasively Predict Axillary Lymph Node Metastasis in Breast Cancer?J. Ultrasound Med.39 (10), 18971905. 10.1002/jum.15294

  • 274

    RackovG.Garcia-RomeroN.Esteban-RubioS.Carrión-NavarroJ.Belda-IniestaC.Ayuso-SacidoA. (2018). Vesicle-Mediated Control of Cell Function: The Role of Extracellular Matrix and Microenvironment. Front. Physiol.9, 651. 10.3389/fphys.2018.00651

  • 275

    RamtekeA.TingH.AgarwalC.MateenS.SomasagaraR.HussainA.et al (2015). Exosomes Secreted under Hypoxia Enhance Invasiveness and Stemness of Prostate Cancer Cells by Targeting Adherens junction Molecules. Mol. Carcinog.54 (7), 554565. 10.1002/mc.22124

  • 276

    RaposoG.StoorvogelW. (2013). Extracellular Vesicles: Exosomes, Microvesicles, and Friends. J. Cel Biol200 (4), 373383. 10.1083/jcb.201211138

  • 277

    RedmerT. (2018). Deciphering Mechanisms of Brain Metastasis in Melanoma - the Gist of the Matter. Mol. Cancer17 (1), 106. 10.1186/s12943-018-0854-5

  • 278

    RenJ.DingL.ZhangD.ShiG.XuQ.ShenS.et al (2018). Carcinoma-associated Fibroblasts Promote the Stemness and Chemoresistance of Colorectal Cancer by Transferring Exosomal lncRNA H19. Theranostics8 (14), 39323948. 10.7150/thno.25541

  • 279

    RicardJ. A.CramerS. W.CharlesR.Gil TommeeC.LeA.BellW. R.et al (2019). Infratentorial Glioblastoma Metastasis to Bone. World Neurosurg.131, 9094. 10.1016/j.wneu.2019.07.142

  • 280

    RobbinsP. D.MorelliA. E. (2014). Regulation of Immune Responses by Extracellular Vesicles. Nat. Rev. Immunol.14 (3), 195208. 10.1038/nri3622

  • 281

    RoccaroA. M.SaccoA.MaisoP.AzabA. K.TaiY.-T.ReaganM.et al (2013). BM Mesenchymal Stromal Cell-Derived Exosomes Facilitate Multiple Myeloma Progression. J. Clin. Invest.123 (4), 15421555. 10.1172/JCI66517

  • 282

    RodriguesG.HoshinoA.KenificC. M.MateiI. R.SteinerL.FreitasD.et al (2019). Tumour Exosomal CEMIP Protein Promotes Cancer Cell Colonization in Brain Metastasis. Nat. Cel Biol21 (11), 14031412. 10.1038/s41556-019-0404-4

  • 283

    RoegelJ. C.BressolletteL.FouilhouxA. C.MartinF.MorandC.MottierD. (1993). Peritoneal Mesothelioma with Bone Metastasis: a Radionuclide Follow-Up. Ann. Med. Interne (Paris)144 (6), 425.

  • 284

    RyuS.-H.HeoS.-H.ParkE. Y.ChoiK.-C.RyuJ.-W.LeeS. H.et al (2017). Selumetinib Inhibits Melanoma Metastasis to Mouse Liver via Suppression of EMT-Targeted Genes. Ar37 (2), 607614. 10.21873/anticanres.11354

  • 285

    SaidN. A. B. M.WilliamsE. D. (2011). Growth Factors in Induction of Epithelial-Mesenchymal Transition and Metastasis. Cells Tissues Organs193 (1-2), 8597. 10.1159/000320360

  • 286

    SaifM. W.GalaninaN.Ravage-MassL.KaleyK.CornfeldD.LambL.et al (20102010). Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer Following Distal Pancreatectomy. Case Rep. Med.2010, 13. 10.1155/2010/634975

  • 287

    SakimuraC.HoriT.DeguchiS.MasudaG.TendoM.NakataB.et al (2019). A Case Report of Lung Resection for Lung Metastasis from Pancreatic Cancer. Gan To Kagaku Ryoho46 (13), 19341936.

  • 288

    SalvadorF.LlorenteA.GomisR. R. (2019). From Latency to Overt Bone Metastasis in Breast Cancer: Potential for Treatment and Prevention. J. Pathol.249 (1), 618. 10.1002/path.5292

  • 289

    SantarpiaM.LiguoriA.D’AveniA.KarachaliouN.Gonzalez-CaoM.DaffinàM. G.et al (2018). Liquid Biopsy for Lung Cancer Early Detection. J. Thorac. Dis.10 (Suppl. 7), S882S897. 10.21037/jtd.2018.03.81

  • 290

    SasakiT.SatoT.NakaiY.SasahiraN.IsayamaH.KoikeK. (2019). Brain Metastasis in Pancreatic Cancer. Medicine (Baltimore)98 (4), e14227. 10.1097/MD.0000000000014227

  • 291

    SatoY.TanakaK.KobayashiY.ShibuyaH.NishigayaY.MomomuraM.et al (2015). Uterine Cervical Cancer with Brain Metastasis as the Initial Site of Presentation. J. Obstet. Gynaecol. Res.41 (7), 11451148. 10.1111/jog.12668

  • 292

    SchwarzD.NiederleT.MünchP.HielscherT.HasselJ. C.SchlemmerH. P.et al (2019). Susceptibility‐weighted Imaging in Malignant Melanoma Brain Metastasis. J. Magn. Reson. Imaging50 (4), 12511259. 10.1002/jmri.26692

  • 293

    SeifertA. M.EymerA.HeidukM.WehnerR.TungerA.von RenesseJ.et al (2020). PD-1 Expression by Lymph Node and Intratumoral Regulatory T Cells Is Associated with Lymph Node Metastasis in Pancreatic Cancer. Cancers12 (10), 2756. 10.3390/cancers12102756

  • 294

    SharmaD.Brummel-ZiedinsK. E.BouchardB. A.HolmesC. E. (2014). Platelets in Tumor Progression: a Host Factor that Offers Multiple Potential Targets in the Treatment of Cancer. J. Cel. Physiol229 (8), 10051015. 10.1002/jcp.24539

  • 295

    SharmaP.LudwigS.MullerL.HongC. S.KirkwoodJ. M.FerroneS.et al (2018a). Immunoaffinity-based Isolation of Melanoma Cell-Derived Exosomes from Plasma of Patients with Melanoma. J. Extracellular Vesicles7 (1), 1435138. 10.1080/20013078.2018.1435138

  • 296

    SharmaS.AlharbiM.KobayashiM.LaiA.GuanzonD.ZuñigaF.et al (2018b). Proteomic Analysis of Exosomes Reveals an Association between Cell Invasiveness and Exosomal Bioactivity on Endothelial and Mesenchymal Cell Migration In Vitro. Clin. Sci. (Lond)132 (18), 20292044. 10.1042/CS20180425

  • 297

    ShattilS. J.GinsbergM. H. (1997). Integrin Signaling in Vascular Biology. J. Clin. Invest.100 (11 Suppl. l), S91S95. 10.1172/jci119500

  • 298

    SherwoodL. M.ParrisE. E.FolkmanJ. (1971). Tumor Angiogenesis: Therapeutic Implications. N. Engl. J. Med.285 (21), 11821186. 10.1056/NEJM197111182852108

  • 299

    ShidaY.HakariyaT.MiyataY.SakaiH. (2020). Three Cases of Brain Metastasis from Castration‐resistant Prostate Cancer. Clin. Case Rep.8 (1), 9699. 10.1002/ccr3.2587

  • 300

    ShutoT.FujinoH.InomoriS.NakayamaS.SatohH.IdeguchiH.et al (1995). Glioblastoma Multiforme with Liver Metastasis-Ccase Report. No To Shinkei47 (8), 772777.

  • 301

    SimonsB. W.DalrympleS.RosenM.ZhengL.BrennenW. N. (2020). A Hemi‐spleen Injection Model of Liver Metastasis for Prostate Cancer. Prostate80 (14), 12631269. 10.1002/pros.24055

  • 302

    SinghR.PochampallyR.WatabeK.LuZ.MoY.-Y. (2014). Exosome-mediated Transfer of miR-10b Promotes Cell Invasion in Breast Cancer. Mol. Cancer13, 256. 10.1186/1476-4598-13-256

  • 303

    SkogJ.WürdingerT.van RijnS.MeijerD. H.GaincheL.CurryW. T.et al (2008). Glioblastoma Microvesicles Transport RNA and Proteins that Promote Tumour Growth and Provide Diagnostic Biomarkers. Nat. Cel Biol10 (12), 14701476. 10.1038/ncb1800

  • 304

    Soler-CardonaA.ForsthuberA.LippK.EbersbergerS.HeinzM.SchossleitnerK.et al (2018). CXCL5 Facilitates Melanoma Cell-Neutrophil Interaction and Lymph Node Metastasis. J. Invest. Dermatol.138 (7), 16271635. 10.1016/j.jid.2018.01.035

  • 305

    SommersC. L.ByersS. W.ThompsonE. W.TorriJ. A.GelmannE. P. (1994). Differentiation State and Invasiveness of Human Breast Cancer Cell Lines. Breast Cancer Res. Tr31 (2-3), 325335. 10.1007/BF00666165

  • 306

    SridharS.Paz-AresL.LiuH.ShenK.MorehouseC.RizviN.et al (2019). Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients. Clin. Lung Cancer20 (6), e601e608. 10.1016/j.cllc.2019.06.020

  • 307

    SruthiT. V.EdattL.RajiG. R.KunhiramanH.ShankarS. S.ShankarV.et al (2018). Horizontal Transfer of miR-23a from Hypoxic Tumor Cell Colonies Can Induce Angiogenesis. J. Cel Physiol233 (4), 34983514. 10.1002/jcp.26202

  • 308

    StanselT.A. WicklineS.PanH. (2020). NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis. J. Cancer Sci. Clin. Ther.04 (3), 256265. 10.26502/jcsct.5079070

  • 309

    StasenkoM.CybulskaP.FeitN.MakkerV.KonnerJ.O'CearbhaillR. E.et al (2019). Brain Metastasis in Epithelial Ovarian Cancer by BRCA1/2 Mutation Status. Gynecol. Oncol.154 (1), 144149. 10.1016/j.ygyno.2019.05.004

  • 310

    SuY. Y.SunL.GuoZ. R.LiJ. C.BaiT. T.CaiX. X.et al (2019). Upregulated Expression of Serum Exosomal miR-375 and miR-1307 Enhance the Diagnostic Power of CA125 for Ovarian Cancer. J. Ovarian Res.12 (1), 6. 10.1186/s13048-018-0477-x

  • 311

    SunH.WangC.HuB.GaoX.ZouT.LuoQ.et al (2021). Exosomal S100A4 Derived from Highly Metastatic Hepatocellular Carcinoma Cells Promotes Metastasis by Activating STAT3. Sig Transduct Target. Ther.6 (1), 187. 10.1038/s41392-021-00579-3

  • 312

    SunL.HeM.XuN.XuD.-H.Ben-DavidY.YangZ.-Y.et al (2018). Regulation of RAB22A by Mir-193b Inhibits Breast Cancer Growth and Metastasis Mediated by Exosomes. Int. J. Oncol.53 (6), 27052714. 10.3892/ijo.2018.4571

  • 313

    SunS.LianX.LiuX.MaJ.HouX.ZhangF.et al (2020). Multimodal Therapy Is a Better Choice for Patients with Brain Metastasis from Cervical Cancer. CmarVol 12, 1239512402. 10.2147/CMAR.S283673

  • 314

    SussmanJ.RosaiJ. (1990). Lymph Node Metastasis. Am. J. Surg. Pathol.14 (9), 819828. 10.1097/00000478-199009000-00003

  • 315

    SuzukiK.YasudaT.NagaoK.HoriT.WatanabeK.KanamoriM.et al (2015). Bone Metastasis of a Gastrointestinal Stromal Tumor: A Report of Two Cases. Oncol. Lett.9 (4), 18141818. 10.3892/ol.2015.2976

  • 316

    SwayneL. C.HedigerR. G.WolffM. (1992). Bone Scan Detection of Pelvic Metastasis from Pleural Mesothelioma. Clin. Nucl. Med.17 (12), 965966. 10.1097/00003072-199212000-00013

  • 317

    SzczepanskiM. J.SzajnikM.WelshA.WhitesideT. L.BoyiadzisM. (2011). Blast-derived Microvesicles in Sera from Patients with Acute Myeloid Leukemia Suppress Natural Killer Cell Function via Membrane-Associated Transforming Growth Factor- 1. Haematologica96 (9), 13021309. 10.3324/haematol.2010.039743

  • 318

    TaharaR. K.BrewerT. M.TheriaultR. L.UenoN. T. (2019). Bone Metastasis of Breast Cancer. Adv. Exp. Med. Biol.1152, 105129. 10.1007/978-3-030-20301-6_7

  • 319

    TakeharaY.EndoS.MoriY.NakaharaK.TakayanagiD.ShimadaS.et al (2014). Malignant Peritoneal Mesothelioma with Lymph Node Metastasis that Originated in the Transverse colon. World J. Surg. Onc12, 112. 10.1186/1477-7819-12-112

  • 320

    TanS.XiaL.YiP.HanY.TangL.PanQ.et al (2020). Exosomal miRNAs in Tumor Microenvironment. J. Exp. Clin. Cancer Res.39 (1), 67. 10.1186/s13046-020-01570-6

  • 321

    TavernaS.FlugyA.SaievaL.KohnE. C.SantoroA.MeravigliaS.et al (2012). Role of Exosomes Released by Chronic Myelogenous Leukemia Cells in Angiogenesis. Int. J. Cancer130 (9), 20332043. 10.1002/ijc.26217

  • 322

    TaylorD. D.Gerçel-TaylorC.LyonsK. S.StansonJ.WhitesideT. L. (2003). T-cell Apoptosis and Suppression of T-Cell receptor/CD3-Zeta by Fas Ligand-Containing Membrane Vesicles Shed from Ovarian Tumors. Clin. Cancer Res.9 (14), 51135119.

  • 323

    TengY.RenY.HuX.MuJ.SamykuttyA.ZhuangX.et al (2017). MVP-mediated Exosomal Sorting of miR-193a Promotes colon Cancer Progression. Nat. Commun.8, 14448. 10.1038/ncomms14448

  • 324

    ThakurB. K.ZhangH.BeckerA.MateiI.HuangY.Costa-SilvaB.et al (2014). Double-stranded DNA in Exosomes: a Novel Biomarker in Cancer Detection. Cell Res24 (6), 766769. 10.1038/cr.2014.44

  • 325

    ThéryC.OstrowskiM.SeguraE. (2009). Membrane Vesicles as Conveyors of Immune Responses. Nat. Rev. Immunol.9 (8), 581593. 10.1038/nri2567

  • 326

    TianX.-P.WangC.-Y.JinX.-H.LiM.WangF.-W.HuangW.-J.et al (2019). Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis. Theranostics9 (7), 19651979. 10.7150/thno.30958

  • 327

    TianX.SunM.WuH.ChenC.LiH.QiuS.et al (2021). Exosome-derived miR-Let-7c Promotes Angiogenesis in Multiple Myeloma by Polarizing M2 Macrophages in the Bone Marrow Microenvironment. Leuk. Res.105, 106566. 10.1016/j.leukres.2021.106566

  • 328

    TokoroT.NakamuraK.HiroseA.NakanumaS.OkamotoK.KinoshitaJ.et al (2018). A Case of Colon Cancer with Brain, Liver and Lung Metastasis Successfully Treated with Bevacizumab Plus Xelox Therapy. Gan To Kagaku Ryoho45 (3), 521523.

  • 329

    TuncerM.FaydaciG.AltinG.ErdoganB. A.KibarS.SanliA.et al (2014). Metastasis of Non-muscle-invasive Bladder Cancer into the Thyroid Gland: a Literature Review Accompanied by a Rare Case. Korean J. Urol.55 (3), 222225. 10.4111/kju.2014.55.3.222

  • 330

    TyagiA.SharmaS.WuK.WuS.-Y.XingF.LiuY.et al (2021). Nicotine Promotes Breast Cancer Metastasis by Stimulating N2 Neutrophils and Generating Pre-metastatic Niche in Lung. Nat. Commun.12 (1), 474. 10.1038/s41467-020-20733-9

  • 331

    UbukataH.MotohashiG.TabuchiT.NagataH.KonishiS.TabuchiT. (2011). Overt Bone Metastasis and Bone Marrow Micrometastasis of Early Gastric Cancer. Surg. Today41 (2), 169174. 10.1007/s00595-010-4389-7

  • 332

    UedaS.OokaH.YamaguchiM.HayashiH.OkayasuT. (1973). Case of Pulmonary Metastasis of Ovarian Cancer Erroneously Diagnosed and Treated as Pulmonary Tuberculosis for a Long Time. Nihon Kyobu Shikkan Gakkai Zasshi11 (11), 684687.

  • 333

    UesatoY.TamashiroK.TakatsukiM. (2020). Long-term Survival after Repeated Resection for Lung Metastasis Originating from Pancreatic Cancer: a Case Report. Surg. Case Rep.6 (1), 66. 10.1186/s40792-020-00832-x

  • 334

    UluçkanÖ. (2019). Mouse Models of Melanoma Bone Metastasis. Methods Mol. Biol.1914, 343348. 10.1007/978-1-4939-8997-3_19

  • 335

    UmezuT.TadokoroH.AzumaK.YoshizawaS.OhyashikiK.OhyashikiJ. H. (2014). Exosomal miR-135b Shed from Hypoxic Multiple Myeloma Cells Enhances Angiogenesis by Targeting Factor-Inhibiting HIF-1. Blood124 (25), 37483757. 10.1182/blood-2014-05-576116

  • 336

    ValadiH.EkströmK.BossiosA.SjöstrandM.LeeJ. J.LötvallJ. O. (2007). Exosome-mediated Transfer of mRNAs and microRNAs Is a Novel Mechanism of Genetic Exchange between Cells. Nat. Cel Biol9 (6), 654659. 10.1038/ncb1596

  • 337

    ValastyanS.WeinbergR. A. (2011). Tumor Metastasis: Molecular Insights and Evolving Paradigms. Cell147 (2), 275292. 10.1016/j.cell.2011.09.024

  • 338

    VouraE. B.RamjeesinghR. A.MontgomeryA. M. P.SiuC.-H. (2001). Involvement of Integrin αvβ3and Cell Adhesion Molecule L1 in Transendothelial Migration of Melanoma Cells. MBoC12 (9), 26992710. 10.1091/mbc.12.9.2699

  • 339

    WanL.PantelK.KangY. (2013). Tumor Metastasis: Moving New Biological Insights into the Clinic. Nat. Med.19 (11), 14501464. 10.1038/nm.3391

  • 340

    WangB.MaoJ.-h.WangB.-y.WangL.-x.WenH.-y.XuL.-j.et al (2020). Exosomal miR-1910-3p Promotes Proliferation, Metastasis, and Autophagy of Breast Cancer Cells by Targeting MTMR3 and Activating the NF-Κb Signaling Pathway. Cancer Lett.489, 8799. 10.1016/j.canlet.2020.05.038

  • 341

    WangC.-F.PengS.-J.LiuR.-Q.YuY.-J.GeQ.-M.LiangR.-B.et al (2020). The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer. Dis. Markers2020, 110. 10.1155/2020/8850873

  • 342

    WangG.XuJ.QiY.XiuJ.LiR.HanM. (2019a). Distribution of Brain Metastasis from Lung Cancer. CmarVol 11, 93319338. 10.2147/CMAR.S222920

  • 343

    WangH.DengQ.LvZ.LingY.HouX.ChenZ.et al (2019b). N6-methyladenosine Induced miR-143-3p Promotes the Brain Metastasis of Lung Cancer via Regulation of VASH1. Mol. Cancer18 (1), 181. 10.1186/s12943-019-1108-x

  • 344

    WangH.WeiM.KangY.XingJ.ZhaoY. (2020). Circular RNA circ_PVT1 Induces Epithelial-Mesenchymal Transition to Promote Metastasis of Cervical Cancer. aging12 (20), 2013920151. 10.18632/aging.103679

  • 345

    WangJ.GuanX.ZhangY.GeS.ZhangL.LiH.et al (2018a). Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts. Cell Physiol Biochem49 (3), 869883. 10.1159/000493218

  • 346

    WangJ.ZhangQ.WangD.YangS.ZhouS.XuH.et al (2020). Microenvironment‐induced TIMP2 Loss by Cancer‐secreted Exosomal miR‐4443 Promotes Liver Metastasis of Breast Cancer. J. Cel Physiol235 (7-8), 57225735. 10.1002/jcp.29507

  • 347

    WangL.TantaiJ.ZhuX. (2020). Katanin P60: a Potential Biomarker for Lymph Node Metastasis and Prognosis for Non-small Cell Lung Cancer. World J. Surg. Onc18 (1), 157. 10.1186/s12957-020-01939-z

  • 348

    WangM.ChaoC.-C.ChenP.-C.LiuP.-I.YangY.-C.SuC.-M.et al (2019c). Thrombospondin Enhances RANKL-dependent Osteoclastogenesis and Facilitates Lung Cancer Bone Metastasis. Biochem. Pharmacol.166, 2332. 10.1016/j.bcp.2019.05.005

  • 349

    WangM.ZhouJ.ZhangL.ZhaoY.ZhangN.WangL.et al (2019d). Surgical Treatment of Ovarian Cancer Liver Metastasis. Hepatobiliary Surg. Nutr.8 (2), 129137. 10.21037/hbsn.2018.12.06

  • 350

    WangN.FengY.XieJ.HanH.DongQ.WangW. (2020). Long Non-coding RNA ZNF667-AS1 Knockdown Curbs Liver Metastasis in Acute Myeloid Leukemia by Regulating the microRNA-206/AKAP13 Axis. CmarVol 12, 1328513300. 10.2147/CMAR.S269258

  • 351

    WangQ.WangG.NiuL.ZhaoS.LiJ.ZhangZ.et al (2021a). Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1. J. Oncol.2021, 113. 10.1155/2021/6617700

  • 352

    WangX.HuL.-P.QinW.-T.YangQ.ChenD.-Y.LiQ.et al (2021b). Identification of a Subset of Immunosuppressive P2RX1-Negative Neutrophils in Pancreatic Cancer Liver Metastasis. Nat. Commun.12 (1), 174. 10.1038/s41467-020-20447-y

  • 353

    WangX.LuoG.ZhangK.CaoJ.HuangC.JiangT.et al (2018). Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis. Cancer Res.78 (16), 45864598. 10.1158/0008-5472.CAN-17-3841

  • 354

    WangX.WangB.ZhanW.KangL.ZhangS.ChenC.et al (2019e). Melatonin Inhibits Lung Metastasis of Gastric Cancer In Vivo. Biomed. Pharmacother.117, 109018. 10.1016/j.biopha.2019.109018

  • 355

    WangX.WangX.ZhuZ.LiW.YuG.JiaZ.et al (2019f). Prostate Carcinoma Cell-Derived Exosomal MicroRNA-26a Modulates the Metastasis and Tumor Growth of Prostate Carcinoma. Biomed. Pharmacother.117, 109109. 10.1016/j.biopha.2019.109109

  • 356

    WangY.LiuW.YuY.LiuJ.-j.XueH.-d.QiY.-f.et al (2020). CT Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer. Eur. Radiol.30 (2), 976986. 10.1007/s00330-019-06398-z

  • 357

    WaqarS. N.SamsonP. P.RobinsonC. G.BradleyJ.DevarakondaS.DuL.et al (2018). Non-small-cell Lung Cancer with Brain Metastasis at Presentation. Clin. Lung Cancer19 (4), e373e379. 10.1016/j.cllc.2018.01.007

  • 358

    WebberJ.SteadmanR.MasonM. D.TabiZ.ClaytonA. (2010). Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation. Cancer Res.70 (23), 96219630. 10.1158/0008-5472.CAN-10-1722

  • 359

    WellsA.YatesC.ShepardC. R. (2008). E-cadherin as an Indicator of Mesenchymal to Epithelial Reverting Transitions during the Metastatic Seeding of Disseminated Carcinomas. Clin. Exp. Metastasis25 (6), 621628. 10.1007/s10585-008-9167-1

  • 360

    WenS.WeiY.ZenC.XiongW.NiuY.ZhaoY. (2020). Long Non-coding RNA NEAT1 Promotes Bone Metastasis of Prostate Cancer through N6-Methyladenosine. Mol. Cancer19 (1), 171. 10.1186/s12943-020-01293-4

  • 361

    WernerssonS.PejlerG. (2014). Mast Cell Secretory Granules: Armed for Battle. Nat. Rev. Immunol.14 (7), 478494. 10.1038/nri3690

  • 362

    WuH.SongS.YanA.GuoX.ChangL.XuL.et al (2020). RACK1 Promotes the Invasive Activities and Lymph Node Metastasis of Cervical Cancer via Galectin-1. Cancer Lett.469, 287300. 10.1016/j.canlet.2019.11.002

  • 363

    WuJ.LiH.XieH.WuX.LanP. (2019). The Malignant Role of Exosomes in the Communication Among Colorectal Cancer Cell, Macrophage and Microbiome. Carcinogenesis40 (5), 601610. 10.1093/carcin/bgy138

  • 364

    XiaY.ZhangB.ZhangH.LiW.WangK. P.ShenH. (2015). Evaluation of Lymph Node Metastasis in Lung Cancer: Who Is the Chief justice?J. Thorac. Dis.7 (Suppl. 4), S231S237. 10.3978/j.issn.2072-1439.2015.11.63

  • 365

    XianX.GopalS.CouchmanJ. R. (2010). Syndecans as Receptors and Organizers of the Extracellular Matrix. Cell Tissue Res339 (1), 3146. 10.1007/s00441-009-0829-3

  • 366

    XiaoD.BarryS.KmetzD.EggerM.PanJ.RaiS. N.et al (2016). Melanoma Cell-Derived Exosomes Promote Epithelial-Mesenchymal Transition in Primary Melanocytes through Paracrine/autocrine Signaling in the Tumor Microenvironment. Cancer Lett.376 (2), 318327. 10.1016/j.canlet.2016.03.050

  • 367

    XieZ.GaoY.HoC.LiL.JinC.WangX.et al (2021). Exosome-delivered CD44v6/C1QBP Complex Drives Pancreatic Cancer Liver Metastasis by Promoting Fibrotic Liver Microenvironment. Gut71, 568579. 10.1136/gutjnl-2020-323014

  • 368

    XingF.LiuY.WuS.-Y.WuK.SharmaS.MoY.-Y.et al (2018). Loss of XIST in Breast Cancer Activates MSN-C-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. Cancer Res.78 (15), 43164330. 10.1158/0008-5472.CAN-18-1102

  • 369

    XuD.LinX.QiuX. (2020a). The Epithelioid Gastrointestinal Stromal Tumor with Pulmonary Metastasis. Medicine (Baltimore)99 (9), e19346. 10.1097/MD.0000000000019346

  • 370

    XuH.XuG. L.LiX. D.SuQ. H.DongC. Z. (2021). Correlation between the Contrast-Enhanced Ultrasound Image Features and Axillary Lymph Node Metastasis of Primary Breast Cancer and its Diagnostic Value. Clin. Transl Oncol.23 (1), 155163. 10.1007/s12094-020-02407-6

  • 371

    XuL.XueF.WangB.YanD.DingW.YinJ.et al (2016). Hoarseness Due to Lymph Node Metastasis of Hepatocellular Carcinoma: A Case Report. Oncol. Lett.12 (2), 918920. 10.3892/ol.2016.4687

  • 372

    XuN.ChenS. H.LinT. T.CaiH.KeZ. B.DongR. N.et al (2020b). Development and Validation of Hub Genes for Lymph Node Metastasis in Patients with Prostate Cancer. J. Cel Mol Med24 (8), 44024414. 10.1111/jcmm.15098

  • 373

    XuY. Y.LuX.MaoY. L.XiongJ. P.BianJ.HuangH. C.et al (2017). The Surgical Treatment of Ovarian Cancer Metastasis between Liver and Diaphragm: a Report of 83 Cases. Zhonghua Wai Ke Za Zhi55 (11), 838841. 10.3760/cma.j.issn.0529-5815.2017.11.004

  • 374

    YamakawaY.MoriguchiM.AramakiT.MitsuyaK.AsakuraK.SawadaA.et al (2015). Brain Metastasis from Hepatocellular Carcinoma: The Impact of Radiotherapy on Control of Intracranial Hemorrhage. Hepatol. Res.45 (11), 10711075. 10.1111/hepr.12457

  • 375

    YamanakaT.TakakiH.NakatsukaA.UrakiJ.FujimoriM.HasegawaT.et al (2013). Radiofrequency Ablation for Liver Metastasis from Gastrointestinal Stromal Tumor. J. Vasc. Interv. Radiol.24 (3), 341346. 10.1016/j.jvir.2012.11.021

  • 376

    YamashitaK.BabaY.KurashigeJ.IwatsukiM.ImaiK.HashimotoD.et al (2016). Co-occurrence of Liver Metastasis of Gastrointestinal Stromal Tumor and Hepatocellular Carcinoma: a Case Report. Surg. Case Rep.2 (1), 86. 10.1186/s40792-016-0212-z

  • 377

    YanT. D.YooD.SugarbakerP. H. (2006). Significance of Lymph Node Metastasis in Patients with Diffuse Malignant Peritoneal Mesothelioma. Eur. J. Surg. Oncol. (Ejso)32 (9), 948953. 10.1016/j.ejso.2006.05.009

  • 378

    YangB.FengX.LiuH.TongR.WuJ.LiC.et al (2020a). High-metastatic Cancer Cells Derived Exosomal miR92a-3p Promotes Epithelial-Mesenchymal Transition and Metastasis of Low-Metastatic Cancer Cells by Regulating PTEN/Akt Pathway in Hepatocellular Carcinoma. Oncogene39 (42), 65296543. 10.1038/s41388-020-01450-5

  • 379

    YangG.-L.LuoT.-H.ZhangH.-Q.LingC.-Q.LiB. (2016). A Case Report of Gastric Cancer with Brain Metastasis: Rare Peripheral Nervous System Symptoms. Oncol. Lett.11 (4), 28932895. 10.3892/ol.2016.4288

  • 380

    YangH.ZhangH.GeS.NingT.BaiM.LiJ.et al (2018). Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells. Mol. Ther.26 (10), 24662475. 10.1016/j.ymthe.2018.07.023

  • 381

    YangS.-S.MaS.DouH.LiuF.ZhangS.-Y.JiangC.et al (2020b). Breast Cancer-Derived Exosomes Regulate Cell Invasion and Metastasis in Breast Cancer via miR-146a to Activate Cancer Associated Fibroblasts in Tumor Microenvironment. Exp. Cel Res.391 (2), 111983. 10.1016/j.yexcr.2020.111983

  • 382

    YaoK.PengC.ZhangY.ZykovaT. A.LeeM.-H.LeeS.-Y.et al (2017). RSK2 Phosphorylates T-Bet to Attenuate colon Cancer Metastasis and Growth. Proc. Natl. Acad. Sci. USA114 (48), 1279112796. 10.1073/pnas.1710756114

  • 383

    YeL.ZhangF.LiH.YangL.LvT.GuW.et al (2017). Circulating Tumor Cells Were Associated with the Number of T Lymphocyte Subsets and NK Cells in Peripheral Blood in Advanced Non-small-cell Lung Cancer. Dis. Markers2017, 16. 10.1155/2017/5727815

  • 384

    YeL.ZhangQ.ChengY.ChenX.WangG.ShiM.et al (2018). Tumor-derived Exosomal HMGB1 Fosters Hepatocellular Carcinoma Immune Evasion by Promoting TIM-1+ Regulatory B Cell Expansion. J. Immunotherapy Cancer6 (1), 145. 10.1186/s40425-018-0451-6

  • 385

    YiH.YeJ.YangX. M.ZhangL. W.ZhangZ. G.ChenY. P. (2015). High-grade Ovarian Cancer Secreting Effective Exosomes in Tumor Angiogenesis. Int. J. Clin. Exp. Pathol.8 (5), 50625070.

  • 386

    YinZ.MaT.HuangB.LinL.ZhouY.YanJ.et al (2019). Macrophage-derived Exosomal microRNA-501-3p Promotes Progression of Pancreatic Ductal Adenocarcinoma through the TGFBR3-Mediated TGF-β Signaling Pathway. J. Exp. Clin. Cancer Res.38 (1), 310. 10.1186/s13046-019-1313-x

  • 387

    YoonA.ChoiC. H.KimH.-J.ParkJ.-Y.LeeY.-Y.KimT.-J.et al (2013). Contributing Factors for Bone Metastasis in Uterine Cervical Cancer. Int. J. Gynecol. Cancer23 (7), 13111317. 10.1097/IGC.0b013e31829da127

  • 388

    YorkJ. E.StringerJ.AjaniJ. A.WildrickD. M.GokaslanZ. L. (1999). Gastric Cancer and Metastasis to the Brain. Ann. Surg. Oncol.6 (8), 771776. 10.1007/s10434-999-0771-3

  • 389

    YoshidaY.HoshinoS.MiyakeT.FukudaS.YamadaK.NaoyaA.et al (2012). Early Start of Chemotherapy after Resection of Brain Metastasis from colon Cancer with Synchronous Multiple Liver Metastases. Case Rep. Oncol.5 (2), 290295. 10.1159/000339614

  • 390

    YouL.-N.TaiQ.-W.XuL.HaoY.GuoW.-J.ZhangQ.et al (2021a). Exosomal LINC00161 Promotes Angiogenesis and Metastasis via Regulating miR-590-3p/ROCK axis in Hepatocellular Carcinoma. Cancer Gene Ther.28 (6), 719736. 10.1038/s41417-020-00269-2

  • 391

    YouX.WangY.MengJ.HanS.LiuL.SunY.et al (2021b). Exosomal miR-663b E-xposed to TGF-β1 P-romotes C-ervical C-ancer M-etastasis and E-pithelial-mesenchymal T-ransition by T-argeting MGAT3. Oncol. Rep.45 (4). 10.3892/or.2021.7963

  • 392

    YouY.ShanY.ChenJ.YueH.YouB.ShiS.et al (2015). Matrix Metalloproteinase 13‐containing Exosomes Promote Nasopharyngeal Carcinoma Metastasis. Cancer Sci.106 (12), 16691677. 10.1111/cas.12818

  • 393

    YousefiM.NosratiR.SalmaninejadA.DehghaniS.ShahryariA.SaberiA. (2018). Organ-specific Metastasis of Breast Cancer: Molecular and Cellular Mechanisms Underlying Lung Metastasis. Cell Oncol.41 (2), 123140. 10.1007/s13402-018-0376-6

  • 394

    YuL.-X.YanL.YangW.WuF.-Q.LingY.ChenS.-Z.et al (2014). Platelets Promote Tumour Metastasis via Interaction between TLR4 and Tumour Cell-Released High-Mobility Group Box1 Protein. Nat. Commun.5, 5256. 10.1038/ncomms6256

  • 395

    YueS.MuW.ErbU.ZöllerM. (2015). The Tetraspanins CD151 and Tspan8 Are Essential Exosome Components for the Crosstalk between Cancer Initiating Cells and Their Surrounding. Oncotarget6 (4), 23662384. 10.18632/oncotarget.2958

  • 396

    YungW. K. A.TepperS. J.YoungD. F. (1983). Diffuse Bone Marrow Metastasis by Glioblastoma: Premortem Diagnosis by Peroxidase-Antiperoxidase Staining for Glial Fibrillary Acidic Protein. Ann. Neurol.14 (5), 581585. 10.1002/ana.410140514

  • 397

    ZengZ.LiY.PanY.LanX.SongF.SunJ.et al (2018). Cancer-derived Exosomal miR-25-3p Promotes Pre-metastatic Niche Formation by Inducing Vascular Permeability and Angiogenesis. Nat. Commun.9 (1), 5395. 10.1038/s41467-018-07810-w

  • 398

    ZhangC.LiaoY.LiuP.DuQ.LiangY.OoiS.et al (2020). FABP5 Promotes Lymph Node Metastasis in Cervical Cancer by Reprogramming Fatty Acid Metabolism. Theranostics10 (15), 65616580. 10.7150/thno.44868

  • 399

    ZhangG.ZhangW.LiB.Stringer-ReasorE.ChuC.SunL.et al (2017). MicroRNA-200c and microRNA- 141 Are Regulated by a FOXP3-Kat2b axis and Associated with Tumor Metastasis in Breast Cancer. Breast Cancer Res.19 (1), 73. 10.1186/s13058-017-0858-x

  • 400

    ZhangH.-G.KimH.LiuC.YuS.WangJ.GrizzleW. E.et al (2007). Curcumin Reverses Breast Tumor Exosomes Mediated Immune Suppression of NK Cell Tumor Cytotoxicity. Biochim. Biophys. Acta (Bba) - Mol. Cel Res.1773 (7), 11161123. 10.1016/j.bbamcr.2007.04.015

  • 401

    ZhangH.DengT.LiuR.BaiM.ZhouL.WangX.et al (2017). Exosome-delivered EGFR Regulates Liver Microenvironment to Promote Gastric Cancer Liver Metastasis. Nat. Commun.8, 15016. 10.1038/ncomms15016

  • 402

    ZhangJ.GaoY.HanH.ZouC.FengY.ZhangH. (2019a). Matrine Suppresses Lung Metastasis of Human Hepatocellular Carcinoma by Directly Targeting Matrix Metalloproteinase-9. Biochem. Biophysical Res. Commun.515 (1), 5763. 10.1016/j.bbrc.2019.04.063

  • 403

    ZhangL.NiuH.MaJ.YuanB.-Y.ChenY.-H.ZhuangY.et al (2019b). The Molecular Mechanism of LncRNA34a-Mediated Regulation of Bone Metastasis in Hepatocellular Carcinoma. Mol. Cancer18 (1), 120. 10.1186/s12943-019-1044-9

  • 404

    ZhangM.SunJ. (2013). Bone Metastasis from Ovarian Cancer. Clinical Analysis of 26 Cases. Saudi Med. J.34 (12), 12701273.

  • 405

    ZhangQ.LenT. Y.ZhangS. X.ZhaoQ. H.YangL. H. (2020). Exosomes Transferring Long Non-coding RNA FAL1 to Regulate Ovarian Cancer Metastasis through the PTEN/AKT Signaling Pathway. Eur. Rev. Med. Pharmacol. Sci.24 (21), 10921. 10.26355/eurrev_202011_23560

  • 406

    ZhangQ.SuoJ.ChangW.ShiJ.ChenM. (2017). Dual-modal Computer-Assisted Evaluation of Axillary Lymph Node Metastasis in Breast Cancer Patients on Both Real-Time Elastography and B-Mode Ultrasound. Eur. J. Radiol.95, 6674. 10.1016/j.ejrad.2017.07.027

  • 407

    ZhangX. (2019). Interactions between Cancer Cells and Bone Microenvironment Promote Bone Metastasis in Prostate Cancer. Cancer Commun.39 (1), 76. 10.1186/s40880-019-0425-1

  • 408

    ZhangY.-F.ZhouY.-Z.ZhangB.HuangS.-F.LiP.-P.HeX.-M.et al (2019c). Pancreatic Cancer-Derived Exosomes Promoted Pancreatic Stellate Cells Recruitment by Pancreatic Cancer. J. Cancer10 (18), 43974407. 10.7150/jca.27590

  • 409

    ZhangZ.LiX.SunW.YueS.YangJ.LiJ.et al (2017). Loss of Exosomal miR-320a from Cancer-Associated Fibroblasts Contributes to HCC Proliferation and Metastasis. Cancer Lett.397, 3342. 10.1016/j.canlet.2017.03.004

  • 410

    ZhaoZ.LiangS.SunF. (2020). LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation. Front. Oncol.10, 1172. 10.3389/fonc.2020.01172

  • 411

    ZhengX.MaN.WangX.HuJ.MaX.WangJ.et al (2020). Exosomes Derived from 5-Fluorouracil-Resistant colon Cancer Cells Are Enriched in GDF15 and Can Promote Angiogenesis. J. Cancer11 (24), 71167126. 10.7150/jca.49224

  • 412

    ZhongY.LuQ.QiuW.LuoY. (2020). LINC00636 Promotes Lymph Node Metastasis and Cervical Cancer through Targeting NM23. Biosci. Rep.40 (10). 10.1042/BSR20200367

  • 413

    ZhouC.-F.MaJ.HuangL.YiH.-Y.ZhangY.-M.WuX.-G.et al (2019). Cervical Squamous Cell Carcinoma-Secreted Exosomal miR-221-3p Promotes Lymphangiogenesis and Lymphatic Metastasis by Targeting VASH1. Oncogene38 (8), 12561268. 10.1038/s41388-018-0511-x

  • 414

    ZhouJ.SunJ.-Y.WuS.-G.WangX.HeZ.-Y.ChenQ.-H.et al (2016). Risk Factors for Lymph Node Metastasis in Ovarian Cancer: Implications for Systematic Lymphadenectomy. Int. J. Surg.29, 123127. 10.1016/j.ijsu.2016.03.039

  • 415

    ZhouW.FongM. Y.MinY.SomloG.LiuL.PalomaresM. R.et al (2014). Cancer-secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis. Cancer Cell25 (4), 501515. 10.1016/j.ccr.2014.03.007

  • 416

    ZhouX.YanT.HuangC.XuZ.WangL.JiangE.et al (2018). Melanoma Cell-Secreted Exosomal miR-155-5p Induce Proangiogenic Switch of Cancer-Associated Fibroblasts via SOCS1/JAK2/STAT3 Signaling Pathway. J. Exp. Clin. Cancer Res.37 (1), 242. 10.1186/s13046-018-0911-3

  • 417

    ZhouZ.ChenL.SherD.ZhangQ.ShahJ.PhamN.-L.et al (2018). Predicting Lymph Node Metastasis in Head and Neck Cancer by Combining Many-objective Radiomics and 3-dimensioal Convolutional Neural Network through Evidential Reasoning*. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc., 14. 10.1109/EMBC.2018.8513070

  • 418

    ZhuH.JiaZ.TrushM. A.LiY. R. (2016). Nrf2 Deficiency Promotes Melanoma Growth and Lung Metastasis. Ros2 (4), 308314. 10.20455/ros.2016.853

  • 419

    ZhuY.-J.ChenY.HuH.-Y.ZhouY.-W.ZhuY.-T.LiuJ.-Y. (2020). Predictive Risk Factors and Online Nomograms for Synchronous Colon Cancer with Liver Metastasis. Front. Oncol.10, 1681. 10.3389/fonc.2020.01681

  • 420

    ZhuoS.ZhouJ.RuanG.ZengS.MaH.XieC.et al (2020). Percutaneous Microwave Ablation versus Surgical Resection for Ovarian Cancer Liver Metastasis. Int. J. Hyperthermia37 (1), 2836. 10.1080/02656736.2019.1706767

  • 421

    ZongZ.-H.DuY.-P.GuanX.ChenS.ZhaoY. (2019). CircWHSC1 Promotes Ovarian Cancer Progression by Regulating MUC1 and hTERT through Sponging miR-145 and miR-1182. J. Exp. Clin. Cancer Res.38 (1), 437. 10.1186/s13046-019-1437-z

  • 422

    ZucchellaM.DezzaL.PacchiariniL.MeloniF.TacconiF.BonomiE.et al (1989). Human Tumor Cells Cultured "In Vitro" Activate Platelet Function by Producing ADP or Thrombin. Haematologica74 (6), 541545.

Summary

Keywords

tumor-derived exosomes, metastasis, pre-metastatic niche, angiogenesis, immunosuppression

Citation

Bai S, Wang Z, Wang M, Li J, Wei Y, Xu R and Du J (2022) Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis. Front. Cell Dev. Biol. 10:752818. doi: 10.3389/fcell.2022.752818

Received

03 August 2021

Accepted

10 February 2022

Published

02 March 2022

Volume

10 - 2022

Edited by

Peti Thuwajit, Mahidol University, Thailand

Reviewed by

Nabanita Chatterjee, The Ohio State University, United States

Paola Massimi, International Centre for Genetic Engineering and Biotechnology, Italy

Updates

Copyright

*Correspondence: Juan Du,

†These authors have contributed equally to this work and share first authorship

This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Cell and Developmental Biology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics